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Abstract
This dissertation shows that biologically meaningful predictions can be made by an-
alyzing images of cells. In particular, groups of related genes and their biological
functions can be predicted using images from large gene-knockdown experiments.
Our analysis methods focus on measuring individual cells in images from large gene-
knockdown screens, using these measurements to classify cells according to phenotype,
and scoring each gene according to how reduction in its expression affects phenotypes.
To enable this approach, we introduce methods for correcting biases in cell im-
ages, segmenting individual cells in images, modeling the distribution of cells showing
a phenotype of interest within a screen, scoring gene knockdowns according to their
effect on a phenotype, and using existing biological knowledge to predict the under-
lying biological meaning of a phenotype and, by extension, the function of the genes
that most strongly affect that phenotype. We repeat this analysis for multiple pheno-
types, extracting for each a set of genes related through that phenotype, along with
predictions for the biology of each phenotype.
We apply our methods to a large gene-knockdown screen in human cells, validating
it on known phenotypes as well as identifying and characterizing several new cellular
phenotypes that have not been previously studied.
Thesis Supervisor: Polina Golland
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Chapter 1
Introduction
This dissertation shows how biologically meaningful predictions can be made by an-
alyzing images of cells. Specifically, the predictions are sets of genes with similar
biological function. In most cases, we also make a prediction for the function, method
of action, or some other common element between those genes, connecting to existing
biological knowledge.
The data for generating these hypotheses come from image-based screens, in which
groups of cells are grown under a wide variety of conditions, then stained and imaged.
Each image is of a group of cells under one of the conditions. In this work, the
images are taken from gene-knockdown screens, in which each condition corresponds
to a particular gene's expression being targeted for suppression. The size of the
experiments discussed here are on the order of a few thousand gene-knockdowns.
Our approach to forming predictions of related genes and their biological function
is outlined in figure 1-1. Within images, we identify individual cells and measure
a large number of features for each cell. These measurements make up the cell's
cytological profile. Using the original images, human guidance, and the cytological
profiles, we build a classifier for each phenotype of interest. For each phenotype, the
corresponding classifier is used to label every cell in the screen according to whether
that cell shows the corresponding phenotype or not. Each gene is scored according to
how reducing its expression affects the relative number of cells showing the phenotype.
The genes and their scores form a phenotype profile. We predict that genes with the
Label Every Related
mages Identify and Cytological - Cell by Phenotypege Measure Cells Profiles Phenotype Profiles Genes
Correlate with Gene
Existing Data Function
Figure 1-1: An overview of our methods. Our goal is to use images of cells to predict
related genes, and their biological function. In order to do this, we first identify and
measure cells in the image, forming a cytological profile for each cell. Using human
guidance, the original images, and the cytological profiles, we build an automatic
classifier for a phenotype of interest. We use this classifier to label every cell according
to whether it shows that phenotype. We then score each gene according to how
reducing its expression affects the fraction of cells with the phenotype. The gene
scores form a phenotype profile. Those genes scoring most strongly are predicted to
be related. We correlate the phenotype profile with existing biological data in order
to predict the biological mechanisms of the phenotype and the genes that affect it.
Italics indicate different forms of data.
strongest effect on the phenotype are related. To predict the underlying biology of
the phenotype, and by extension the function of the genes that affect it, we look
for correlations between the phenotype profile and existing biological data, such as
annotated sets of genes or expression profiles.
Our goal in this work is to expand and improve the tools for analyzing large, image-
based screens, in particular gene-knockdown screens. Although sequencing projects
have made it possible to identify almost all of the genes in several organisms, little is
known about the function of most of these genes. Our methods allow us to predict
which genes are related within the cell, from their common effect on cell appearance,
as well as function, by comparison to existing biological knowledge.
1.1 Making and Interpreting Predictions from
Gene-Knockdown Screens
This work relies on the following fundamental assumption:
If two genes produce a similar appearance in cells when knocked
down, that is evidence that they have a similar biological func-
tion.
This is perhaps obvious, given that the appearance of cells is a result of the
expression of their genes in combination with their environment, but it is worth
stating outright.
We will quantify similarity of appearance by analyzing specific phenotypes. Thus,
our predictions about genes' similarity and functions are based on which knockdowns
cause cells to exhibit a particular phenotype more or less often than others. In this
work, we define a phenotype as a binary trait, which a cell does or does not possess.
It may be visually apparent (qualitative) or defined by cytological measurements
(quantitative). This approach is slightly artificial, as there exist continuous-valued
phenotypes, such as size of a cell or the concentration of a particular protein within
the cell. We do not deal with such phenotypes here, though some of our methods
could be adapted to these phenotypes. Prior approaches to analyzing images of cells
have generally scored images as a whole [52], or measured individual cells but taken
the mean of these values to score images [31]. In contrast, we follow a cell-centric
approach to improve our ability to detect changes that might otherwise be lost because
the phenotype is present in only a fraction of cells due to natural cell-to-cell variability
or low penetrance of the phenotype [60].
Some phenotypic differences may only manifest themselves under specific cellular
conditions. Any two genes with different sequence have some difference in function;
however, we may not be able to detect this difference without very targeted experi-
mentation. For the same reason, two genes with many functions in common may still
cause very different phenotypes in an experiment, due to whatever slight differences
there are between them. These caveats indicate that we should be aware that any
predictions are only hypotheses that must be evaluated via further experimentation.
To label cells by phenotype, we first process the images in order to identify and
measure individual cells. The combined measurements for a cell form its cytological
profile. From cytological profiles, cells can be classified according to whether they
present a particular phenotype or not. In some cases, the phenotype can be identified
by thresholding a single or small number of measurements in the cytological profile.
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Figure 1-2: Examples of cellular phenotypes. These phenotypes are easily identified
visually, but not easily measured via image processing. (The cell images have been
color-reversed for printing. Compare to figure 2-3)
For example, a cell's total amount of DNA, an indicator of its progress through the
cell cycle, can be measured by totalling the intensity of the DNA stain in the nucleus.
In other cases, the cellular phenotype may be a morphological change, such as a
crescent-shaped nucleus or cells with long projections, as illustrated in Figure 1-2. In
these cases, a single measurement is unlikely to capture the difference between cells
with and without the phenotype. To handle these phenotypes, we build automatic
classifiers that distinguish between phenotype-positive and phenotype-negative cells.
In either case, thresholding a few measurements or using an automatically trained
classifier, we label every cell in the screen as having the phenotype or not.
Once individual cells have been classified as having a phenotype or not, we iden-
tify which gene knockdowns enhance or suppress that phenotype, by identifying genes
that cause the fraction of cells showing the phenotype under that treatment to be
significantly higher or lower than expected. We fit a model to the distribution of
phenotype-positive and phenotype-negative cells. Those genes that deviate signifi-
cantly from the model have the largest effect on the phenotype of interest, and are
putatively related through their common (or opposite) effects on cells.
However, if we concentrate on only the genes with the most significant effect on
a phenotype, we neglect much of the information available from the screen. The
continuum of scores, one for each gene targeted in the screen, has information about
how each gene affects the phenotype, even those that do so less strongly. Such genes
may be only peripherally involved in the cellular process producing the phenotype,
but the full set of screen-wide scores and their relative effects can provide insights
into what cellular processes are involved in producing the phenotype of interest.
In order to interpret the full set of scores from a screen, we treat them as a
phenotype profile, analogous to an expression profile. Expression profiles are large-
scale measurements of gene expression, captured via microarrays [85], and quantifying
for each gene on the microarray how its expression (i.e., activity) changes between two
conditions (e.g., control and treated) or classes of cells (e.g., malignant versus benign
tumors). Phenotype profiles operate in the opposite direction: for each gene, we
measure how the phenotype of a cell changes when that gene's expression is perturbed,
rather than how that gene is perturbed in cells of a particular phenotype. As is done
with expression profiles, we look for correlations between the phenotype profiles and
biological data using previously developed tools [89, 55].
1.2 Related Work
The application of automatic image analysis to cell images, and large screens in
particular, is relatively new. Until recently, large screens were analyzed by researchers
examining and scoring individual images by eye [27, 52]. Some groups have developed
automatic image analysis methods; though these have been designed to score single
phenotypes rather than for general applicability [62, 78, 101], they do demonstrate
that image analysis can be a powerful tool for biological discovery. There are several
vendors of commercial software for cell image analysis [35], usually bundled with
automated microscopes, but these methods are proprietary and are seldom described
technically, are difficult to extend with new algorithms, and do not provide access to
the raw data they collect, limiting the analysis methods available to the user.
The fundamental operations in our cell image processing are illumination correc-
tion, cell identification, and measurement of individual cells, each applied in a modular
fashion. The illumination correction methods we have developed are related to meth-
ods from the MRI literature for bias field estimation, in particular those by Wells et
al. [98] and van Leemput et al. [58]. We rely on automatic thresholding methods for
initial nuclear foreground identification, primarily the histogram-based method intro-
duced by Otsu [77]. To separate individual nuclei within the foreground, we borrow
freely from others' work on identifying, segmenting, and separating clumped nuclei
in images, especially from the work of Wahlby et al. [93, 94].
We introduce a new method for segmenting cells in images, in which we compute
Voronoi regions of nuclei in a manifold with a metric guided by image features. Our
method is a generalization of fixed-offset methods, such as those used by Perlman et
al. [78], which do not take into account image features in locating boundaries, and
watershed-based methods [70], which rely solely on image features. Our algorithm
shows some similarities with Geodesic Active Contours et al. [19]. After cells have
been segmented, we measure them in a variety of ways, to form a cytological profile
for each cell. The features we have chosen have been guided by prior work on cell
image analysis [13, 81].
Processing the images from a screen produces a large database of measurements
for every cell in the screen, with each cell associated with one of the gene-knockdowns
in the screen (in a many-to-one relationship). To make predictions about related genes
and genetic function, we identify which cells have a particular phenotype, for which we
sometimes make use of automatic classifiers. Our method of training these classifiers
is similar to Example-Based Image Retrieval [91], implemented with GentleBoosting
[33].
Automatic classification has been applied to images of cells, previously. Boland
& Murphy use neural networks to classify staining of subcellular compartments in
individual cells [13]. Danckaert et al. [23] perform a similar task using a modular
neural network and multiple images from confocal microscopy. Both of these methods
have yet to be applied to questions of gene function. Support vector machines have
been used by Harder et al. to classify fluorescently-tagged nuclei according to phase
in the cell cycle in gene knockdown experiments [40, 41, 53], as part of the MitoCheck
project [3]. Support vector machines with a linear decision boundary were used by
Looet al. [64] to classify drug-treated cells versus controls; they then extract the
normal to the decision boundary as a signature for the drug's phenotypic effect, for
use in characterization of drugs via similarity of effect on phenotype.
Our representation of the output of a screen as phenotype profiles, and the use of
these profiles to find correlation with existing biological data to predict gene function,
is unique to the best of our knowledge. Others have examined screens' output as a
distribution across gene knockdowns of phenotype-based scores [32], but not used the
continuous nature of the scores directly. Rather, they interpret the scores as evidence
that signalling networks within the cell are more complex and graded than usually
presented.
1.3 Contributions
The primary contributions of this work are new image analysis techniques for cell
images, and methods for analyzing and understanding data from large, image-based
cell screens.
Accurate per-cell measurements are the foundation of our approach to predicting
gene function. To improve the quality of our measurements, we must correct for bi-
ases introduced by experimental conditions and imperfections in instrumentation. We
adapt techniques for bias image correction from the field of MRI processing [58, 98] to
handle correction of illumination and staining variation in large screens. To improve
segmentation and measurements of individual cells in images, we introduce a new
method for identifying cell boundaries. This method works well even when cells are
crowded, based on computing the Voronoi diagram of the cells' nuclei under a met-
ric controlled by image features. Our illumination correction and cell segmentation
methods are discussed in chapter 3, in conjunction with the full image-processing
system.
We make several contributions in the area of analyzing data from large screens.
In chapter 4, we apply automatic classifiers to label cells according to whether they
have a particular phenotype, based on example-based image retrieval. In chapter
5, we introduce a model for the distribution of phenotype-positive and phenotype-
negative cells, and use this model to score genes according to how they affect the
relative number of phenotype-positive cells. We show in chapter 6 how we can use
the continuum of scores to predict the underlying biology of the phenotype, and by
extension, the function of the genes that most strongly affect that phenotype. We
apply our methods to images from a large gene-knockdown screen in human cells [71],
validating it on known phenotypes as well as identifying and characterizing several
new cellular phenotypes that have not been previously studied.
We would like to emphasize that the work described in this dissertation was per-
formed as part of the CellProfiler project [17]. CellProfiler is an open-source software
platform for analyzing large collections of cell images, designed in particular for han-
dling the output of large gene-knockdown screens. It has hundreds of users worldwide
[1], and is being continually improved. The image processing methods described here
have all been incorporated into this system. The phenotype-based analysis techniques
we describe here are being incorporated into a companion system, CellVisualizer [2],
which will be released in the coming months.
Chapter 2
Biological Background
In order to establish context and motivate this work, it is useful to provide a brief
overview of gene-knockdown screens. However, a full understanding of the biological
basis for such screens is not necessary to comprehend the goals and methods in this
dissertation. For a more detailed discussion of gene knockdown and other types of
screens, the interested reader is directed to the review by Carpenter and Sabatini [18].
2.1 Gene-Knockdown Screens
Genome sequencing projects provide the information necessary to identify almost all
of the genes in several organisms, including humans. However, little is known about
most of these genes and their purpose within the cell. There are several methods by
which gene function can be predicted, such as looking for genes with similar sequence
within and across species [14], or using similarities in the patterns of gene expression
as an indicator of similarity of function [90, 95]. However, these methods are often
quite noisy and are significantly removed from the true situation of interest, in vivo
biological function. In particular, expression profiling measures the average response
of cells, rather than their individual behavior [60]. Knockout organisms or cell lines,
in which a gene has been excised or otherwise inactivated by direct modification of
the DNA coding that gene, can be created in the lab, but only via expensive and
low-throughput methods.
A powerful and high-throughput method to explore gene function is to make use
of the existing machinery for gene regulation in the cell. RNA interference (RNAi),
discovered in Caenorhabditis elegans worms in 1998 by Fire et al. [29], allows the sup-
pression of a gene's activity by introduction of long double-stranded RNA (dsRNA)
into an organism or cells in culture. This leads to cleavage and degradation of comple-
mentary messenger RNA before it can be translated from mRNA to its corresponding
protein, silencing the expression of the targeted gene. This allows biologists to easily
silence a single gene, and study the effect of its removal.
In Drosophila melanogaster, (fruit flies, a common model organism for genetics
experiments), long dsRNA (>150-800 nucleotides) can be injected into embryos or
introduced into some cell lines in culture. In mammalian cells, long dsRNA in cells
induces nonspecific cell death. To work around the cells' natural defenses, dsRNAs
around only 20-25 nucleotides long, called small interfering RNAs (siRNAs), are used,
though in general, siRNAs are less effective than long dsRNAs. To silence a particular
gene, a subsequence from that gene is chosen as the target for the siRNA. The process
of RNAi gene knockdown is illustrated in figure 2-1.
A given siRNA's effectiveness varies depending on the particular genomic subse-
quence it targets, in ways that are not well understood. For this reason, it is common
to produce several siRNA constructs targeted to the same gene, with the hope that
one will be effective at reducing the expression of that gene. Further complicating
matters, RNA silencing does not require a perfect match between nucleotides, so
off-target hits are an issue even when a siRNA's sequence is chosen to be unique to
the targeted gene. Targeting multiple, nonoverlapping subsequences of the gene also
helps control for off-target effects, in which a siRNA matches to more than one gene's
sequence.
An effective method for delivering siRNA into cells is via a virus engineered with
DNA encoding a short hairpin RNA (shRNA), essentially an siRNA with the two
complementary strands joined at one end. The virus injects its payload into the cell,
which then integrates randomly into the host cell's DNA. The cell then expresses the
shRNA, knocking down the targeted gene via RNA interference, and passes on the
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Figure 2-1: Gene transcription and translation, and gene silencing by short interfer-
ing RNA (siRNA) or short hairpin RNA (shRNA). In the normal course of events
(the upper path), a gene is transcribed from the DNA into messenger RNA (mRNA),
which is then translated into a protein within the cell. When siRNA or shRNA are
present (the lower path), they combine with the RNA induced silencing complex. The
complex cleaves mRNA with the complementary subsequence, preventing its trans-
lation to protein, and silencing the gene's expression. In the illustration above, red
indicates the gene's targeted subsequence, and green the complementary subsequence.
DNA producing the shRNA to daughter cells during replication.
The process to create a virus carrying the DNA for a particular shRNA can go
astray in a variety of ways, and the eventual product may not function as intended.
To help account for the variability in effectiveness of viral infection and delivery of
the DNA, the construct includes an antibiotic-resistance gene, which is integrated
into the cell in the same way as the DNA coding the shRNA. This confers resistance
on cells in which the infection by the virus and integration of the DNA are successful,
allowing selection for successfully infected cells by treating them with the antibiotic.
Large libraries of viral constructs targeting every gene in the human genome,
with several constructs per gene, are being produced. Much of the data used in this
dissertation comes from one of the first screens performed using such a library [71],
a ML
Cell I ISpot
Figure 2-2: High-throughput screening formats. (a) multiwell plates. Each well
contains a gene-knockdown reagent, and cells are added to the wells. The bottoms
of the well are transparent, allowing cells to be imaged after fixing and staining. (b)
Living cell microarrays. Reagents are printed as spots on a glass slide, then cells are
grown on the surface of the slide. Cells that grow on a spot take up the reagent at
that spot. Cells are fixed, stained, and imaged on the slide. (Figure from Carpenter
and Sabatini [18]).
with each shRNA applied to cells in a different well of a multiwell plate, as in figure
2-2(a). We also use data from living cell microarrays, in which spots of dsRNAs are
printed on glass slides, and Drosophila cells are grown directly on the slides, as in
figure 2-2(b). At the printed spots, cells take up the dsRNA and the targeted genes
are knocked down.
In both cases, after cells have grown for some time under gene knockdown condi-
tions they are fixed and stained, then imaged with a robotic microscope. A typical
image from a screen is shown in figure 2-3. Each image from this step corresponds
to cells grown under a different condition, i.e., with a different knockdown. A single
screen might target from a few thousand to a few tens of thousands of genes. Screens
with long dsRNAs in Drosophila cells typically have one long dsRNA per gene, with
2&ca4p-
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Figure 2-3: A typical image from a gene-knockdown screen. The blue channel is a
stain for DNA, showing the nuclei, the red channel shows actin, a cytoskeletal protein,
providing cell outlines, and the green channel is a stain for phospho-histone H3, a
nuclear marker for division in the cell cycle (appearing as teal due to overlapping
the nuclei). This image is of HT29 cells, a human colon cancer line, grown under a
control condition (i.e., no gene is actually knocked down in these cells).
multiple replicates in each screen for quality control. In human cell screens, which
use the less consistent shRNAs, each gene in the screen might be targeted by 5 or
more hairpins, again with replicates to improve data quality. In virus-based screens,
at least one replicate will be treated with the antibiotic to which infected cells are
resistant. Comparison of the number of cells in antibiotic treated versus untreated
conditions gives an estimate of infection efficiency of each virus. This allows us to
distinguish knockdown of a gene critical to cell survival, in which case both conditions
show few cells, from one in which the viral construct failed in some way, in which
only cells treated with the antibiotic die.
It is important to note that the particular stains chosen to prepare the cells for
imaging affect which visual features we have available to measure. We can probe
only a small subset of the cells' appearance in any one experiment, primarily due to
the small number of stains that can be applied to cells and separated during imaging
(usually three or four). For data to be collected for individual cells with the methods
in the next chapter, it is necessary to at least label the nucleus of the cell, usually by
staining the DNA with a fluorescent dye. If information about cell shape and size is
desired, some cytoskeletal protein such as actin must be stained, as well, leaving room
for only one or two more stains (with current technology). Therefore, it is important
to choose which proteins should be stained carefully, based on the goals of the screen.
For instance, a screen exploring genetic regulators of the cell cycle benefit most from
stains for one or more proteins known to vary in concentration during the cell cycle.
Lab automation and these screens' natural parallelism makes it feasible to con-
duct a large screen in about a week. The next step is analyzing the images from
the screen in order to extract biologically relevant information. Some large screens
have been conducted using visual inspection at this step (e.g., [52]), but experiments
based on this approach are prone to human error and subjective bias, are difficult to
replicate, and tedious. Automatic image analysis offers a much more effective manner
of analyzing these screens.
Chapter 3
From Images to Cytological
Profiles
This chapter describes the image processing techniques that allow us to identify and
measure individual cells in images. The steps in this process, outlined in figure 3-1,
are correcting illumination and staining variation, identification of individual nuclei,
from which we identify individual cells, and measurement of the cells. We demonstrate
and validate a new method for correcting illumination and staining variation in large
screens, and a new method for cell segmentation.
When we process images from a screen, the goal is to identify individual cells in the
set of images and to measure the properties of each cell. Illumination and staining
variation corrupt these measurements by biasing image intensities. To correct for
illumination and staining variation, we must model and correct their effects on image
formation. As most measurements depend on a cell's shape, area, or masked pixels,
it is similarly necessary to find the boundaries of cells with a good level of accuracy.
Images Correct Illumination Identify dentify Measure Cytologicaland Staining Variation Nuclei Cells Cells Profiles
Figure 3-1: Steps in the image processing pipeline. Images are first corrected for
illumination and staining variation, then nuclei and cells are identified, and cells are
measured. The results are cytological profiles, one for every cell in the set of images.
With these goals, the image processing proceeds as follows. First, we separate the
foreground and background of the image for nuclei via automatic thresholding. Then,
overlapping and clumped nuclei are separated using a combination of morphological
and intensity-based heuristics. Algorithms for nuclear segmentation and declumping
have been developed previously by several researchers; we borrow freely from their
methods and adapt them as needed. After nuclei are identified, we identify the cellular
foreground using the same methods as for nuclei. Then, the cell body corresponding
to each nucleus is identified by assigning each pixel in the cellular foreground to one
nucleus, via an algorithm based on the Voronoi diagram of the nuclei in a metric space
defined by image differences in the cell-body stained image. Finally, each nucleus and
its cell are measured in a variety of ways, based on their shape and staining pattern.
These methods are implemented as part of the CellProfiler image analysis software
[17].
3.1 Illumination and Staining Variation
All physical experiments are subject to noise and biases; large screens are no excep-
tion. There are many sources of error, but the two most dominant are illumination
variation, due to imperfections in the microscope's optical path or imager, and stain-
ing variation, from different concentrations of stain applied to different locations on
a slide or plate.
The effect of illumination variation is apparent in the images in figure 3-2(a), in
which a full set of 5600 DNA-stained images from a large screen are averaged together
(see figure 2-3 for an example of a single DNA and actin stained image). Between the
boundary and the middle of the image, there is a relative difference of 1.5 in mean
intensity. The density of cells is nearly uniform, however, as shown in figure 3-2(b),
as determined by processing images to identify and locate nuclei. Note that a flat
cell distribution is not the case in all experiments, particularly well-based screens.
The physical dimension of each image is small enough (- 100 Pm) that variation of
staining concentration across the image is not a reasonable explanation. Although it
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Figure 3-2: Mean intensity of the DNA-stained channel versus actual cell density,
for a screen of 5600 gene-knockdowns, on the left. The mean staining image shows a
variation of a factor of roughly 1.5 from the edge to the middle of the image. However,
the distribution of nuclei, on the right, is almost fiat, indicating that the intensity
variation is due to illumination and optical path imperfections in the microscope.
NB: the distribution of cells is not always uniform, as in this case.
is possible that some biological change in the cells has resulted in a different amount
of stain entering the cell, or changing the affinity of stain and DNA, the far simpler
explanation is that the illuminant, optical path, and image sensor of the microscope
have introduced a bias in intensity.
Staining variation causes biases in images at larger scales. For example, figure
3-3 shows the median DNA staining for cells, computed separately for each image
in a screen. Each imagewise median is plotted according to the physical location on
the glass slide from where that image was taken. As the gene knockdowns in this
experiment were randomly ordered, the large-scale variation in median DNA staining
intensity is almost surely due to varying concentration of stain applied to the slide.
If illumination and staining variation are not corrected before segmenting and
measuring cells, the resulting measurements are significantly degraded. In figure 3-4,
histograms of DNA content for each cell in a screen (the same as produced the data
in figures 3-2 and 3-3) are shown before and after corrections for illumination and
staining are applied. Prior to correction, it is difficult to separate the subpopulations
of cells in 2N (2 copies of each chromosome) and 4N (4 copies, prior to cellular
division). After correction, these subpopulations are easily distinguished. We use
n.0
100.0
90.0
80,0
70.0
60.0
50.0
40.0
Figure 3-3: Median nuclear DNA staining intensity, calculated for each image, and
plotted in a grid corresponding to the physical location on the slide where the image
was captured. The large-scale variation in median nuclear DNA stain is probably due
to varying DNA stain concentration.
kV ONA S "t kV I)NA mrnnntm
(a) Before correction (b) After correction
Figure 3-4: (a) Histogram of cellular DNA content (plotted on a log scale), for all
cells in a screen (- 14, 000, 000 cells), measured without correcting illumination and
staining variation. (b) The same data, after correcting illumination and staining
variation.
integrated DNA staining intensity, computed within the nucleus, as a proxy for DNA
content.
3.1.1 Correcting Illumination and Staining
The Physical Model of Image Formation
It is useful to consider a simplified physical model of how images of cells are formed
in the experiments we are considering, in order to understand how to correct biases
introduced by illumination and staining variation.
The value of a pixel is essentially a product of several variables: illumination in-
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tensity, stain concentration within the image, and the stained protein's concentration
within a cell at that location. We include optical path transparency and camera
sensitivity into the illumination intensity, since they act in concert and in the same
manner. Our goal is to measure the amount of protein within each pixel (in arbitrary
units), without the biases of the other two terms. We assume that the optical path
and illuminant are fixed from image to image. We also assume that staining concen-
tration does not vary across the image, and that in slide-based experiments, the stain
concentration varies slowly between adjacent images (see chapter 2 for a discussion
of the two screening formats).
In mathematical terms, we have
image.,Y,ij ~c cX,y * *I,Y  sij, (3.1)
for a pixel at x, y in an image located at physical position i, j within the experiment,
with illumination function 1 and protein concentration at c varying with x, y, and
staining concentration s varying with i, j. We wish to control for the variation in 1
and s, in order to measure c. Note that c and s are essentially images in this context;
below we will simplify their form by modeling s via a basis and representing c via a
mixture model.
This model assumes that the concentrations of proteins (and their affinity for
staining) do not vary depending on image position. This is probably not strictly
correct, especially since we know the density of cells varies based on image position in
some cases, and this implies a biological cause that presumably could affect protein
levels, as well. However, we expect this effect to be significantly smaller, in general,
than that due to illumination. This is an area where further work would be of value.
Most existing approaches to correcting illumination for image-based cell screens
operate on single image at a time and assume a fiat distribution of cells [26, 40],
usually by fitting a smooth function to the intensity image, and using that function
as the illumination correction 1. Unfortunately, this conflates cell density in the image
with illumination intensity. Especially in well-based screens, cell density can vary
significantly within an image. Furthermore, these approaches require post-processing
to adjust for staining variation. We avoid both of these difficulties with our approach.
Modeling and Correcting Illumination and Staining Variation
In order to correct illumination and staining variation, it is necessary to estimate how
they vary from pixel to pixel or location to location on the slide, respectively.
We do this by randomly sampling pixels from each image, recording their log-
transformed intensities in the multiple staining channels as well as their location in
the image and physical layout within the experiment. The log-transformation converts
the multiplicative model from equation 3.1 to an additive one. If we assume that the
noise from each log-transformed term is roughly Gaussian (observed experimentally,
see figure 3-5), then each pixel is drawn from a distribution of the form
log Px,y,i,j - ac Ar(pc + Lx,y + Si,j, c), (3.2)
C
where Px,y,i,j,c is the pixel at location x, y in image coordinates and i, j in the slide
(or physical layout) coordinates. The illumination function L varies with x, y (see
figure 3-2). The staining S varies with i, j (see figure 3-3). The pixel class c depends
on where within (or without) a cell the pixel was sampled from, and could be any
of the subcellular compartments (nucleus, cytoplasm, some other stained organelle)
or background. The distribution of classes is modeled by the mixing coefficients ac,
and the different compartment-dependent correlations between stains by their mean
intensities V, and covariance matrices Ec. Note that we treat pixels as multidimen-
sional vectors, and will correct all staining channels simultaneously. We will set c
to the number of visually distinguishable staining compartments, usually three for
background, cell body, and nucleus. To make the model identifiable, we constrain L
and S to have zero mean; this does not reduce the model's power, as we are operating
in the log-intensity domain, where linear shifts correspond to scaling the images by a
positive constant.
Expectation-Maximization for Modeling Variation
Our goal is to estimate the illumination L,,, and staining variation Sij in equation
3.2. We represent these as linear combinations of some smooth basis set B, separating
the basis elements of L and S for simplicity. As discussed above, each element of B
has zero mean, to ensure the model is identifiable. The bases are combined according
to the coefficients f. Rewriting equation 3.2,
log px,y,ij - E~ ac Af(pc + Bx,y,i,jf, Ec), (3.3)
C
we can then derive the equations necessary to optimize this model's parameters 0 =
{a, p, E, f}, via Expectation-Maximization [4], the standard approach with mixture
models where we do not know class labels a priori.
For simplicity of notation, we replace px,y,i,j with p. and B,y,ij with B,. We write
the log-likelihood of the model as
£(0) = Elogp(pn;9 ) (3.4)
= log p(pn, zn; 8), (3.5)
n Zn
where zn are the hidden class labels (i.e., background plus subcellular compartment
types) of the pixels, and the interior summation is over all possible labelings z, for
pixel p?. For any distribution Q, over the z,, we have
4(0) = log p(pn,z ; 0) (3.6)
l Zn
= log Qn(z?)p(p %'z ;O) (3.7)
n Zn Qn(Zn)
> E : Qn%(Zn%)log9P(Pn, Zn; 0) (3.8)Ž C ~Qn(z,)log Qn(Zn) (3.8)
n Zn 
Qn
where we have applied Jensen's inequality in the last step. If we choose Qn(zn) to
be the posterior distribution of the zn given the current estimate for the parameters
0, then the bound is tight at 0 = 0 [79]. In the EM algorithm, we will repeatedly
maximize the lower bound of equation 3.8 to find a new 0t+l based on the current Ot.
In the E-step of the algorithm, we find Q,(z,) = p(znlp; O6), which we will write
as z(C ) with c the probability for each possible label.
In the M-step, we maximize the lower bound of equation 3.8 to find Ot+l,
= argmax
0
= argmax E
S n C
= argmax
0
n c
= argmax E E
{a,plErf n c
Q (zn) log p(pn, Zn; O)&n(Q h)zlog
P(Pn, Zn c; Ot)
z() log(c
zn
ZM lop(Zn = c; Ot)P(PnZn = c; Ot)
Zn
ace(_' lo ( fT (pn-,-Bn f))z log
Zn (27-)d/2 Ec 1/2
where d is the
maximize this
(except for ac,
dimension of the pixel data, in this case the number of channels. To
expression, we take the partial derivatives w.r.t. the elements of 0
as it is a special case which we will deal with separately),
V (...) =)(·> (pn - Bnf) - Ec-lc) (3.13)
n
VZ(...)=c) (EC1 + i 1 _(p c - Bnf)(pn- pc - Bn f)TEC-1)(3.14)
n
Vf...) = z(C)B E n - Pc - Bnf), (3.15)
n C
where we have written partials as gradients to deal with the multiplicity of dimensions
and parameters for each mixture c.
The standard approach at this point would be to set these each to zero, and
solve simultaneously for the update of 0,+1. However, this is difficult because of the
nonlinear dependence between the solutions for p, E, and f. To make this tractable,
we will split the EM algorithm into two phases: an EM update of {a, p, E} followed
by an EM update of {a, f}, during each of which the other variables are held constant.
This is essentially coordinate ascent, with a single EM optimization along the active
0t+1 (3.9)
(3.10)
(3.11)
(3.12)
coordinates. Note that we are still guaranteed to improve the log-likelihood in each
pair of steps, as
(V,,0(...) = 0 and Vf(...) = 0) =-> V,,,f(...) = 0. (3.16)
Before detailing the full algorithm, we return to the case of ac. We have the
constraint that Ec ac = 1, which we deal with by adding a Lagrange multiplier term
A(1 - Ec a,) to equation 3.12. Taking the partial derivative,
(C)
V, = a c- \, (3.17)
which we rearrange to get
ac =. (3.18)
n
Summing over c, and taking into account the constraint and the definition of z c) ,
allows us to solve for A
(C)
ac = (3.19)
C C n
1 = z c) (3.20)
C n
A = E E z (c)  (3.21)
C n
A z: (3.22)
n c
S= 1 = N, (3.23)
n
where N is the number of pixels, which we can now substitute back into equation
3.18 to give the update rule for a,
ac n A) (3.24)
We now detail the full algorithm.
E-step 1
Z (c) = p(zp; Ot) (3.25)
M-step 1: {a,up,E}
(C)
aZ = N (3.26)
( C) (p, - Bf)
PC = ( f) (3.27)
En zc)(Pn - ic - Bnf)(pn - Pc - Bf)T
e z () (3.28)
where in 3.28 equation pc should be the value from 3.27. We then update Ot with
a, /p, E from the above to get Ot+.
E-step 2
z (4c) = p(Zn pn; Ot+) (3.29)
M-step 2: {a, f}
We repeat the update for a,
ac = ZN (3.30)
n
Then, for f, we have from equation 3.15,
(Z zBc)B ) B $ f - z cBEi (p - Ic). (3.31)
n C n C
n(C)T--IB o h
We solve this equation using the pseudoinverse of (Zn c zc) EB, AB), to handle
cases such as an undercomplete basis in B. We then update 0t+½ with the new values
for f to get Ot+l.
The summations in equation 3.31 can be rewritten in tensor algebra in a straight-
forward manner, allowing us to represent the set of Bn's across all pixels as as a
3-dimensional tensor (# channels x # pixels x # basis elements), and other el-
ements as matrices and vectors. This significantly simplifies and accelerates our
implementation.
Note that we could update p in the second M-step, as well, while holding only
E constant, as the relation between the optimal values for /p and f is linear. This
would probably result in improved performance. We choose not to make this change
to simplify the implementation. Sampling pixels from the thousands of images that
make up a screen takes much more time than to compute the illumination and staining
correction, and the algorithm has never failed to converge, so there is not much
impetus for making this improvement.
This method is easily adapted to both slide-layout and plate-layout experiments.
On slides, staining variation is present as a large-scale, smooth function over (i, j).
In plate-based experiments, plate-to-plate variation is modeled with a single offset
per plate. If there are known sources of possible plate-pattern biases within the
experiment (from moving from 96-well to 384-well plates, for example [83]), these can
be incorporated into the bases as well. Illumination variation is modeled with smooth
functions, usually one set per channel.
As empirical justification for modeling pixel distributions as a mixture of Gaus-
sians, in figure 3-5 we show the distribution of pixel values (post-correction), for a
few million randomly sampled pixels from a screen of 5600 gene knockdowns. Two
channels for each pixel were sampled, one of DNA staining, another staining actin,
a cytoskeletal protein. Three groups of pixels can be discerned, corresponding to
background, cytoplasm (the cell body outside the nucleus), and the nucleus itself.
The groups are roughly Gaussian. In practice, our method works well even when the
pixel distributions are not well-modeled by a Gaussian.
This approach for correcting illumination and staining variation is similar to some
methods of bias field correction in the field of MRI analysis [58, 98]. Our approach
differs in that we have a large number of images to correct, which we reduce to a
manageable number of pixels via random sampling, and the combination of staining
and illumination variation. In many respects, the problems of staining variation and
bias field correction can be solved by similar methods. We have explored an entropy-
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Figure 3-5: Distribution of pixel values for two staining channels, actin and DNA. A
2D histogram of pixel values, randomly sampled from a screen of 5600 gene knock-
downs. The horizontal axis corresponds to the log-intensity of the actin-stained chan-
nel. The vertical axis is the log-intensity of the DNA-stained channel. Three popu-
lations are visible: background pixels (lower left) have low DNA and actin staining
intensity. Pixels from the cytoplasm (lower right) have brighter actin staining, but
low DNA stain. Pixels taken from nuclei (upper right) have bright DNA and actin
staining. The individual groups are roughly Gaussian.
minimization approach, similar to congealing methods for bias field correction [57],
but do not make use of it for reasons of efficiency.
We have not explored how well the pixel data from screens actually matches
our shifted Gaussian mixture model, nor explored in depth how well we find the
correct mixture components in practice. However, it has been our experience that
we get nearly identical results even when the fit is incorrect, in the sense of one
physical component (from figure 3-5) capturing more than one component in the
model (leaving the remaining two to be modeled by a single Gaussian). This is
probably because the model's likelihood is improved if the illumination and staining
corrections are more accurate, even when the mixture model is poor. This goes back to
our original (and necessary) assumption, that the protein density varies independently
of the illumination and staining variation.
3.2 Identifying Nuclei
The next step in identifying cells is locating and separating individual nuclei. We
identify nuclei and cells separately because nuclei are more consistent in shape, are
more physically separated than their enclosing cells, and are easily and routinely
stained in experiments. Methods to identify and separate individual nuclei have been
developed by several researchers in the past [67, 70, 76, 93, 94], and we borrow freely
from their work, modifying their approaches to suit our needs. The full explanation
of our methods for identifying nuclei is given in the documentation of the CellProfiler
project [1]. Here we only summarize the methods which we have used, and do not offer
separate validation of these algorithms beyond that already available in the relevant
literature.
We first threshold the log-transformed nuclear channel, with an automatic method
such as that developed by Otsu [77], or by fitting a mixture-of-Gaussians to pixel
values and classifying each pixel according to the resulting model. Note that we do
not generally use the mixture model from the illumination correction step at this
point, because in many cases gene knockdowns change the distribution of intensities,
increasing or decreasing the amount of a particular protein in the cells, or cause nuclei
and cells to spread out or shrink, changing the concentration of proteins and causing a
mismatch between the screen-wide pixel distribution and that of the individual image.
For these reasons, we prefer to calculate the threshold for each image independently,
though we have considered using information from the illumination correction step
as a prior to guide the choice of a threshold. We include an upper and lower limit on
the threshold to catch outlier images, such as those with no cells.
The threshold from the automatic method is often scaled to adjust for cases where
the images slightly violate the model implied by the automatic thresholding algorithm.
Applying the adjusted threshold gives a foreground mask which we must then separate
into individual nuclei.
Figure 3-6: Human cells stained for DNA (nucleus), showing the nuclei. When nuclei
stain uniformly, and have a smooth and round morphology, we use morphological
operations to separate clumped and overlapping nuclei.
Nuclear appearance varies greatly depending on the type of screen, the cell line,
the staining protocol, and other experimental factors. We have developed a variety
of methods for separating nuclei, in the interest of being flexible enough to handle
most cases.
If nuclei are fairly uniform in staining and round in shape, as in figure 3-6, then
we usually use a morphological approach to separate clumped nuclei. We apply a
distance transform to the binary nuclear mask, replacing each foreground pixel with
its distance to the boundary. We then locate maxima in the distance image, and treat
these as the nuclear centers. If nuclei are less uniform in shape and stain, as in figure
3-7, we smooth the nuclear stain image and locate maxima in that smoothed image,
limited to the foreground pixels.
After identifying maxima, we filter them to remove those that are too close to one
another (as defined by the user and adjusted from screen to screen). If two maxima
are within the minimum separation, the one with larger magnitude is kept (or one is
randomly chosen if they are equal).
To find the nuclear border for each maximum identified as a nuclear center, we use
Figure 3-7: Drosophila melanogaster Kc cells stained for DNA, and their segmenta-
tion. For cell lines and protocols that produce nuclei with less smooth staining and
without a smooth shape, we use intensity-based methods to separate overlapping and
clumped nuclei. Compare to figure 3-6.
one of two methods. If nuclei show a difference of intensity between their interiors and
borders under the staining protocol, we use a watershed transform of the intensity
image with the centers as imposed minima. If nuclear shape is consistently round
or there is insufficient information in the nuclear channel to identify boundaries, we
identify the nuclei as the Voronoi regions of the filtered maxima, confined to the
foreground mask.
Finally, nuclei that are above or below user-specified size thresholds are marked
for rejection. Large nuclei continue as seeds to identify and separate cells, as discussed
in the next section, while small nuclei are treated as noise and removed.
3.3 Identifying Cells
Once nuclei have been identified and separated, we use them as "seed" regions to
identify individual cells. ý We make the simplifying assumption that each cell has
only a single nucleus, to speed up image processing, even though there are cases
where this is not true. In particular, knockdown of genes that are critical to division
in the cell cycle can result in cells with multiple nuclei. Although the one-to-one
nucleus-to-cell assumption results in inaccurate measurements for the rare binucleate
and multinucleate cells, this is not much of a concern. Using automatic classifiers
(discussed in the next chapter), we can still identify binucleate and multinucleate cells,
and can similarly keep them from polluting the quantification of other phenotypes.
The first step in identifying cells is to threshold the cell-staining channel, to get
a foreground and background mask, as we did for nuclear identification. As with
nuclei, this thresholding is achieved via one of several automatic techniques. Given
the mask, identifying individual cells corresponds to assigning each foreground pixel
to one of the previously identified nuclei. Our method is based on two heuristics:
first, a cellular-foreground pixel is more likely to correspond to a nearby nucleus
rather than a far one, and second, a pixel is more likely to correspond to a nucleus
with few image boundaries separating them than one with many boundaries between
the pixel and the nucleus.
Previous approaches to cell segmentation have been based on one or the other
of these heuristics. The watershed transformation [11, 93] is guided by boundaries
(peaks or valleys) in the image, but neglects spatial distance. It is therefore sensitive
to small gaps in the staining of cellular borders, which are common in our experience,
and lead to dramatic missegmentations in many cases. Voronoi regions of nuclei,
often implemented as fixed offsets or "donuts" around the nuclei [78], do not take
into account image information. Furthermore, fixed offsets inhibit analysis of cell size
and morphology changes.
Our approach combines image and spatial information to segment cells. We define
each cell as the Voronoi region of its corresponding nucleus in the Voronoi diagram of
all of the nuclei, constrained to the cellular foreground mask, as in figure 3-8. However,
the Voronoi diagram is computed in the image under a metric that balances image
information and spatial distance. The metric is defined in terms of the cell-stained
image I and a regularization parameter A, as
Vg(z)VgT (z) + AlG= + (3.32)
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+Figure 3-8: Our cell segmentation algorithm takes as input the stained image of the
cell (the red channel, in the case above) and a labeling of individual nuclei. The cell-
stain channel is thresholded and a single cell per nucleus is identified as the Voronoi
diagram of that nucleus, computed under a metric guided by features in the cell-stain
image and constrained to the thresholded foreground.
where I is the 2 x 2 identity matrix. The function g maps images to images, and in
our application is generally a small-radius blur. Infinitesimal distances under G are
measured by
Ildxll1 dxTGdIx = (dxTVg(I))2 + A(dxTdx) (333)
A+1
The first term in the numerator of this equation, (dxTVg(I))2 , increases distances
measured along directions of steep gradients in g(I). The second term, A(dxTdx) 2 , is
a weighted Euclidean distance and serves as a regularizer with strength parameterized
by A. The regularization effect can be seen by
lim IldxI2G = dxTdx = Ildxll , (3.34)
A-+oo
i.e., as A increases, G becomes more Euclidean, and the identified cells more like the
Voronoi regions without image information.
This metric is similar to that used in Geodesic Active Contours [19], except our
goal is to find the nearest nuclei (i.e., shortest paths) without crossing image bound-
aries, while in Geodesic Active Contours, the goal is to find shortest path following a
boundary. The connection is described more fully in section 3.3.2, below.
The behavior of the metric follows our intuitions of cell appearance and shape. In
the absence of information in the image, such as edges, pixels are associated with the
closest nucleus. If a pixel is roughly equidistant to two nuclei, it is associated with
the nucleus which has the least change in the image between the cell and the nucleus.
We demonstrate the behavior of our algorithm on synthetic data in figure 3-9, where
the tendency to a more Euclidean behavior can be seen as the regularization term A
increases. The effect of image noise on our algorithm is shown in figure 3-10. Note
that in the noisy examples less regularization (i.e., a lower value for A) is needed
to achieve qualitatively similar segmentations. In effect, increasing noise provides a
form of regularization by decreasing the relative magnitude of the gradient near edges
versus smooth (but noisy) areas of the images.
It is interesting to contrast the details of our algorithm with the probabilistic
segmentation algorithm of Ljosa and Singh, which they developed to segment neurites
in retinal cells [63]. They model the segmentation problem as a random walk on the
pixels, with transitions steps dependent on image intensities. The main differences
are that our method computes (implicit) shortest paths from nuclei to pixels, while
probabilistic segmentation takes into account all paths, and our method produces a
binary segmentation while theirs produces a soft assignment.
Another possible approach, not yet explored to our knowledge, would be to use
affinity propagation [30] to identify cells and nuclei by treating cells as individual
clusters, with affinity related to image similarity. Cluster centers could be constrained
to be within nuclei, and labeling of pixels within a cell would correspond to identifying
which pixels belong to a particular cluster (i.e., nucleus).
3.3.1 Validation
To validate our method, we collected a set of manual segmentations by an expert,
for 16 images with roughly 80 cells per image. The manual segmentations included
nuclei and cells, and were performed in conditions as close to our algorithm above as
possible: first the nuclei were outlined, based solely on the nuclear image, then the
cells were segmented, using only the cell image and prior nuclear segmentation.
We use these images for validation of our algorithm. For fairness in comparison we
use hand-outlined nuclei (rather than automatically identified nuclei), and define the
cellular foreground mask as the union of cells identified in the manual segmentation
Figure 3-9: Our segmentation algorithm applied to synthetic images. The input
image is in the upper left, with seed sites marked with dots. From left to right across
the two rows, the resulting distances calculated with our metric are shown, with the
resulting segmentation overlaid white lines, for A equal to 0.2, 0.3, 0.4, 0.5, 0.6, 0.8,
and 3.0. The segmentation lines follow the ridges in the distances function. As can
be seen, as A increases, the segmentation approaches the Voronoi diagram of the seed
regions.
Figure 3-10: Our segmentation algorithm applied to noisy synthetic images. The
same input as in Figure 3-9 is used, with zero-mean Gaussian noise with standard
deviation 0.5 added to each pixel. Edges were 1.0 and background was 0.0 before
noise was added. The layout is the same as in Figure 3-9, but with A equal to 0.025,
0.05, 0.075, 0.1, 0.125, 0.2, and 0.75.
(slightly expanded), rather than from the automatic segmentation.
These choices allow us to evaluate the cell segmentation algorithm's ability to cor-
rectly locate boundaries between cells without propagating errors in nuclear segmen-
tation or thresholding the cellular foreground. For similar reasons, we only evaluate
the algorithm on borders between cells that are neighbors in both the manual and
automatic segmentations. To evaluate the performance of the algorithm, we quantify
the difference between such twice-occurring borders.
When evaluating the algorithm, we use the one-sided signed distance from the au-
tomatic segmentation to the manual segmentation (negative inside the lower-indexed
manually labeled cell, and zero at the manual border) . We set A in (3.32) to 0.05
times the distance between the average foreground and background pixel intensities
on a per-image basis. This value for A was found to be close to optimal in our ex-
periments, with fairly stable behavior for a reasonably large range (within a factor
of two). Our test set includes a wide variety of cell types, with different sizes and
morphologies. In general, most screens would have more homogeneous data, to which
A would be tuned for the entire screen.
Sixteen images made up the test set. Each image was roughly 512x512 pixels on
a side, with cells roughly 25 pixels in diameter, and 80 cells per image on average.
Across the entire set, there were 21,600 pixels on a cell-cell boundary in the automatic
segmentation. A histogram of their signed distances with respect to the manual
segmentation is shown in Figure 3-11. Sixty-four percent (14,000) of the boundary
pixels in the automatic segmentation are within 2 pixels from the corresponding
manual boundary. Ninety-two percent (19,800) of the boundary pixels are within a
distance of 5. The accuracy of the hand-labeling is around 3 pixels, based on the
width of the marker used to outline the cells.
We illustrate the behavior of our method on some typical and worst-case cell
images in figure 3-12 taken from the validation set.
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Figure 3-11: Combined histogram for the signed distances and cumulative distribution
of absolute distances from automatic segmentation to manual segmentation for all
sixteen images in our test set.
3.3.2 Connection to Geodesic Active Contours
Our algorithm is related to Geodesic Active Contours [19]. The full details of their
work are not given here, but we discuss the connection briefly.
Active contours can be seen as finding a shortest path in a Riemannian space,
where distances between pixels are defined by an edge stopping function h : R+ -+ R+ .
Examining equation (8) from Caselles et al. [19] helps establish the similarity:
Minj h(j VI(C(q) ) C'(q) dq (3.35)
where I is the image, C(q) is the curve on image that we are minimizing over, and q
is the parameter along the curve. The edge stopping function h is strictly decreasing
and positive, with h(oo) = 0. The effect of h's interaction with VI is such that the
minimum curve follows larger gradients in the image.
The minimization can be written as (equation (12) of [19])
Min h(IVI(C(s) )ds (3.36)
where s is the arclength parameter for C, and L(C) is the length of C. Therefore,
active contours can be seen as seeking a minimum length curve where the length
(a) Typical cell segmentation results.
(b) Five worst cases, compared to hand-drawn boundaries.
Figure 3-12: (a) Typical segmentation results, compared to hand-drawn boundaries.
(b) Five worst cases, from our hand-drawn boundaries validation set (1280 cells),
as measured by maximum distance between hand-drawn and automatically located
boundaries. In both (a) and (b), the top rows show the outlined nuclei (manually
segmented) overlaid on the cellular stain for two adjacent cells, the second rows the
automatic segmentation boundary between the cells from our method, and the bottom
row the manual segmentation boundary.
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depends on image characteristics [19].
Our goal is different from active contours, since we aim to define boundaries
between regions corresponding to nuclei. However, we do seek implicit shortest paths
with a distance metric controlled by image characteristics. We do not wish to follow
image boundaries, as in active contours, but rather to avoid crossing them. The
metrics in the two approaches differ, specifically in their treatment of edges in the
image: edges in the active contour setting make points along an edge closer under
the Geodesic Active Contours metric, while our metric makes the points across the
edge more separated. Moreover, active contours use a directionally uniform metric,
while ours is not. Our metric separates points across a boundary, but points along a
boundary (perpendicular to the image gradient) are essentially the same distance as
equivalently spaced points in a uniform image region.
Overall, the goal is the same in the two approaches, namely, to allow the com-
putation of inter-pixel distances that simplify the problem at hand and map it to a
simpler framework. In both cases, the problem reduces to that of finding shortest
paths. For active contours, this is often a jumping-off point to more powerful and
efficient methods such as level-sets. In contrast, we employ Dijkstra's algorithm [24]
to find the shortest paths.
3.4 Measuring Cells
After cells have been segmented from the background and each other, they are mea-
sured along a number of axes. Many of the features we measure have been found
useful in other automated cell-image analysis research [13, 81]. The full catalog of
features that we measure is detailed the paper describing the CellProfiler project [17].
We measure intensity, texture, and morphology for each of the compartments of
the cell: the nucleus, the cytoplasm, and the entire cell. As many biological processes
are confined to inter- and intracellular membranes, we treat the nuclear and cellular
boundaries as (thin) compartments in the cell, as well. Intensity measures include
the total, mean, variance, minimum, and maximum intensity of each staining channel
within a cellular compartment. We measure the correlation between each pair of
stains. Texture is measured according to the Haralick and Gabor texture features
[34, 39], though generally not in boundaries because they are not wide enough for
texture measurements to be meaningful.
Area and shape measures include such measures as total area, perimeter, eccen-
tricity, solidity, and several Zernike moments [51]. These measurements are performed
for the binary mask of each of the the cellular compartments.
To capture some information about intercellular interactions, we measure the dis-
tance to each cell's nearest two neighbors, the angle between those neighbors, and the
amount of cellular border shared with other cells. These measures are useful for iden-
tifying missegmentations from previous steps, particularly binucleate and multinucle-
ate cells that have been incorrectly separated into multiple cells by our mononuclear
assumption (cf. section 3.3).
The set of measurements that we capture has been chosen based on previous work,
but this set could bias later analysis, or limit what sort of analysis is possible. Our
general approach has been to include measurements we know to be useful and mean-
ingful (cell size, total intensity of the various stains, boundary contact information,
etc.) along with features previously found to be useful in automatic analysis of cell
images (Zernike moments for shape, Gabor texture features for intensity, etc.). In the
interest of simplicity, we do not usually adjust this set from screen to screen, nor do we
try to trim it down to a smaller set in the interest of capturing more meaningful set of
measurements. In general, we expect the measurement set to be "overcomplete," and
have not explored either feature selection or design of more relevant features (though
the particular classifier that we use for phenotype identification, discussed in the next
chapter, has inherent feature-selection properties.).
We term the combination of measurements made for a single cell its cytological
profile. A typical screen contains tens of millions of cells, each of which yields a
cytological profile. Cytological profiles are grouped by the gene knockdown or other
condition that the cells were grown under. A group of cytological profiles, grouped
by gene knockdown, are shown in figure 3-13.
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Figure 3-13: Cytological Profiles grouped by which gene knockdown was applied to
the cells (captioned at right). Roughly 300 features are measured for each cell, some
of which are highly correlated with other features. A typical screen includes a few
hundred cells for each gene knockdown, a few thousand knockdowns, and a few million
cells overall. Red indicates larger and green lower values, and values have been mean
centered and normalized by standard deviation across all cells. (Image from Noa
Novershtern.)
In the next chapter, we discuss how once the measurements are collected, we use
them, with human guidance, to train automatic classifiers for labeling cells according
to phenotype.
3.5 Summary
In this chapter we presented methods for processing a set of images from a screen in
order to identify individual cells and measure a large number of features for each one,
including cell shape, size, staining texture, and morphology.
As a first step in this measurement process, we introduced a simple model of
image formation and presented a method to correct illumination and staining vari-
ation in large screens, via this model. We use Expectation-Maximization steps to
alternately optimize the parameters of a mixture model for pixel values, in turn with
the coefficients of smooth correction functions for illumination and staining variation.
Our method is applicable to very large sets of images, which we reduce to a manage-
able amount of data via subsampling. Our method avoids some problems with other
approaches, such as conflating cell density and illumination intensity.
We introduced a novel segmentation algorithm for separating individual cells
within an image. This method is based on a regularized metric that varies according
to image features, such that cell boundaries are guided to edges in the image. We have
validated this algorithm on a variety of cell types with highly variable morphology
and appearance (cf. section 3.3.1).
Chapter 4
From Cytological Profiles to
Phenotypes
In the previous chapter, we described how images are processed to identify and mea-
sure individual cells, generating cytological profiles for every cell in the images from
a screen. In this chapter, we use the cytological profiles to label cells according to
whether they have a particular phenotype or not.
The phenotype of interest may be defined by a single or a small set of measure-
ments whose biological meaning is easily interpreted, such as DNA content of the
nucleus (an indicator of a cell's phase in the cell cycle). Phenotypes might be visually
apparent, such as crescent-shaped nuclei or cells with long projections. These phe-
notypes can be identified from cellular measurements, but constructing classification
rules by hand is difficult. We use machine learning to create an automatic classifier
for each phenotype we want to analyze, via a method similar to Example-Based Image
Retrieval [91], in which a user hand-labels examples in an iterative fashion to build
and improve an automatic classifier.
We can easily repeat this process for several phenotypes, after the images have
been processed and cells measured. For each new phenotype, we perform the analyses
in the following chapters, as well.
Figure 4-1: A diagram of the cell cycle.
Cells in the G1 phase have two copies of
each chromosome (2N, see text). During
the G1 phase cells grow and prepare for
DNA duplication and mitosis (cell divi-
sion). After sufficient growth, cells en-
ter the synthesis (S) phase, and duplicate
GO their DNA to produce four copies of each
chromosome (4N). They then enter an-
other growth and preparation phase (G2),
before beginning mitosis (M), in which
the cell separates into two daughter cells
(both 2N). The daughter cells then return
rl /" "I 1 NY 11 I/
to the Gi phase. Cells can enter (tem-
porarily or permanently) a resting phase(GO).
4.1 From Measurements to Phenotypes
Some phenotypes are defined in terms of a few measurements available directly from
the image processing step, such as total DNA content or whether some protein is
stained in the cell above a threshold. We call these phenotypes simple, since we can
usually define rules by hand to label cells according to their phenotype. In other
cases, the phenotype is visually apparent, but a connection to the measurements in
the cytological profiles is difficult to establish by hand. In this case, we build an
automatic classifier to label the cells, guided by human input.
4.1.1 Simple Phenotypes
In some cases, a small number of measurements may define a phenotype that is easily
understood, in biological terms. For instance, the total intensity of the DNA stained
channel measured within a nucleus is roughly proportional to the total amount of
DNA in that nucleus. Given our segmentation of each nucleus as part of the image
processing for a screen, this total amount is easily calculated for each cell, as are
other easily interpretable measurements such as cellular area or mean intensity of the
stained proteins in the nucleus or entire cell.
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Figure 4-2: Identifying phase of the cell cycle from measurements of DNA and
phospho-histone H3, a marker for mitosis. The central plot shows a 2D histogram for
all cells in a screen (roughly 14 Mcells). The horizontal axis shows total DNA stain
in the cell nucleus, on a log-scale. The vertical axis shows the mean phospho-histone
H3 stain in the cell nucleus. Along the bottom of the histogram, two subpopulation
are obvious, one corresponding to cells in G1 (lower-left) and one to G2 (lower-right).
Above these are subpopulations of cells with the same amount of DNA as those below,
but expressing phospho-histone H3. The upper-right subpopulation is of cells enter-
ing mitosis, and about to divide, and in the upper-left, cells that have just divided to
form two daughter cells. Four randomly selected exemplars from each of the boxed
regions are shown to the sides of the histogram, marked by arrows: small, rounded
nuclei (G1/2N, lower left), larger nuclei that have duplicated their DNA (G2/4N,
lower right), condensed nuclei, in preparation for cell division (early M-phase, 4N,
upper right), and just-divided daughter cells (late M-phase, 2N, upper left). (Figure
adapted from [46], data from [71])
An example of a phenotype that can be easily extracted from measurements is
a cell's approximate phase in the cell cycle. In the cell cycle, shown schematically
in figure 4-1, a cell begins in a growing phase (Gl), duplicates its DNA during a
synthesis phase (S), enters a second growth phase (G2), undergoes mitosis, in which
it divides into two daughter cells (M), after which the two daughter cells return to
the first growth phase (Gl). If cells are stained for both DNA content and one or
P.
Mitotic cellsDaughter cells
more markers for specific phases of the cell cycle, it is possible to use a few simple
measurements to label cells according to their phase, as demonstrated in Figure 4-2,
where a two-dimensional histogram of measurements are plotted for the full set of cells
in a screen. The horizontal axis shows total DNA content of the nucleus. The vertical
axis corresponds to mean staining intensity in the nucleus for phospho-histone H3, a
marker for mitosis (M phase). At the lower edge of the plot, there are two obvious
subpopulations, corresponding to cells in G1 (left), with the normal complement of
DNA (two copies of each chromosome, or 2N), and G2 (right), which have duplicated
their DNA (four copies, or 4N). Above each of these are corresponding subpopulations,
of cells in which phospho-histone H3 is being expressed, corresponding to cells that
are about to divide (upper right, 4N and phospho-histone H3 positive), and cells
that have just divided (upper left, 2N and phospho-histone H3 positive). During the
cell cycle, cells move from subpopulation to subpopulation in the counter-clockwise
direction.
Also shown in the figure are randomly selected exemplar cells from each subpop-
ulation, bracketing the histogram. As can be seen, the 2N/G1 nuclei are about half
the size of the 4N/G2 nuclei. The 4N cells expressing the highest levels of phospho-
histone H3 (upper right) are about to separate into two daughter cells, and show the
typical nuclear morphology in which the chromosomes have condensed in preparation
for separation. Finally, in the upper left, the cell has divided into two daughter cells,
each with the normal complement of DNA (2N), but still expressing phospho-histone
H3. Soon after this phase, the cells return to G1 and begin the cell cycle again.
In the plot, there are several other subpopulations visible with other amounts
of DNA (8N, 16N, as well as 3N cells that are phospho-histone H3 positive). The
cell line used in this screen is derived from cancer cells, and has known aneuploidy
defects (abnormal chromosome number). Cells with non-integral copy numbers are
present, though usually only while in the process of duplicating DNA. Some of these
subpopulations are caused by these cellular defects; others are due to experimental
error (during imaging, some wells were underilluminated), or image processing failures
(e.g., very large nuclei are sometimes divided into two or more smaller nuclei).
4.1.2 Complex Phenotypes
In many cases, we are interested in a phenotype that is too complex to be captured in a
small number of measurements, but which can be easily recognized by eye. Examples
of such are shown in figure 1-2. For such phenotypes, we rely on user guidance to
build a training set of positive and negative examples. The user interacts with an
automatic classifier in a feedback loop, similar to example-based image retrieval [91],
to improve the classifier's performance.
To train a classifier, the user starts with a few images of cells showing the pheno-
type of interest. They label these cells as phenotype-positive, and a few other cells
(usually randomly selected) as phenotype-negative. They can then train a classifier
on this limited set, and use the resulting classifier to request more phenotype-positive
or -negative cells. Cells are drawn randomly from the entire screen, automatically
labelled according to the current iteration of the classifier, and once a sufficient num-
ber of the requested type are found, presented to the user. Almost always, there are
mislabeled cells in this set in the early stages of training a classifier. The user can
correct these errors and iterate, until the classifier is sufficiently accurate.
Once the user is satisfied with the classifier's performance, it can be applied to
the entire screen. The total number of phenotype-positive and phenotype-negative
cells for each knockdown can be tallied. These counts can then be analyzed using
methods described in the following chapters.
There are several benefits to using classifiers to label cells' phenotypes. The clas-
sifiers' greater flexibility allows us to screen for phenotypes that can not be analyzed
by more traditional methods, such as by total image intensity or translocation assays
[27], and pre-screen assay development is simplified, as the screened phenotype can
be chosen from a much wider class. For the same reason, phenotypes can be screened
with greater specificity, increasing experimenters' confidence that they are measur-
ing what they intend [28]. Since we can train a new classifier for each phenotype
of interest, we can mine a single screen multiple times, essentially re-screening for
each phenotype. Finally, classifiers help adjust for errors in the image analysis phase,
e.g., missegmented nuclei and cells, provided the errors are consistent and affect the
measurements such that they can be identified by the classifier (i.e., image processing
errors have an identifiable "phenotype").
There are some limitations to our approach. The iterative training we use to
build the classifier results in a biased sample from the set of positive and negative
cells. Therefore, we have no way of knowing that the automatic classifier has not
mislabeled significant subpopulations that have not been encountered. Since most of
the interesting phenotypes we find tend to be a small fraction of the total cells (in
some cases < 1%), we know of no efficient way to correct this. Randomly sampling
and labeling the large number of cells required to build sufficient coverage of the
phenotype-positive and -negative classes would be prohibitive.
Our approach to building classifiers works particularly well when the biologist
performing the screen has positive and negative controls for the phenotype of interest,
which is often true. In this case, cells from the positive and negative controls can
be used to create the training set directly. In other cases, they may be interested in
outliers and interesting phenotypes present but not directly related to the goals of the
screen. We have explored some methods for finding novel phenotypes. The space of
cellular measurements is of a very high dimension (> 300 features), only a few of which
are relevant to any particular phenotype. We discovered the example phenotypes
in figure 1-2 through a variety of methods: plotting measurements we expected to
produce notable phenotypes, e.g., area, perimeter versus area, size versus intensity,
etc. for individual cells as well as averages for each knockdown and looking for outliers;
chance encounters, particularly during training classifiers for other phenotypes; and
taking some examples from a previous analysis of the screen [71]. In general, we do
not have a complete solution to the problem of phenotype discovery.
4.2 GentleBoosting for Cell Classification
GentleBoosting is an ensemble method introduced by Friedman et al. [331. Ensemble
classifiers are built by combining simpler classifiers to create a more powerful com-
bined classifier. The overall classifier is built in a series of rounds, during each of
which a single weak classifier is added to the ensemble.
We use GentleBoosting in conjunction with decision stumps (decision trees with
a single node) whose inputs are the raw measurements from our cell image processing
system. We use GentleBoosting because it is easy to implement, robust to noise, and
has been shown to outperform other boosting variants in similar image classification
tasks in computer vision [61]. Other benefits are that the output of the boosting
algorithm can be parsed by a human to a reasonable degree, and can be written into
a simple and fast query for application to the full database of cell measurements.
We summarize the GentleBoosting algorithm here, briefly. This explanation is
adapted from Torralba et al. [92].
At each step of the GentleBoosting algorithm, we seek to choose a single decision
stump, or weak learner, to add to our ensemble classifier. The choice is made to
minimize the weighted squared error,
N
Jse = i(zi - hm(vi))2, (4.1)
i=1
where J,,,e is the weighted squared error summed over the examples, N the number
of training examples, wi their weights, zi their labels (-1 or +1), hm is the mth weak
learner, and vi the ith training example. For decision stumps, the weak learners take
the form hm(vi) = a6(v{ > 9) + bS(v{ < 0), where a and b are the output parameters
of hm, v{ is the fth component of vi, 0 a threshold function, and 6 the indicator
function, 1 when its argument is true and 0 otherwise. The parameters of hm are
chosen by iterating over every measurement f, and every possible threshold 0 for that
measurement. The outputs a and b can be found via weighted least squares,
Ci wizi6(vý > 0)a = i wiz(v[ > ) (4.2)
Z, wi6(v{ > 9)
b = wz,(v[ < 0) (4.3)
i w59(v{ 9)
59
The weak learner with lowest weighted error according to equation 4.1 is added to
the ensemble (via summation of the hms). The examples weights are then updated
according to
wi +- wie - z- hm (v ) ,  (4.4)
which reweights examples according to how well they are classified by the combined
classifier after adding hm. The complete classifier is given by H(vi) = Em h,(vi).
The example weights are initially set to balance the total weights of positive and
negative examples, in accordance with the advice in Kinh and Viola [91], since our
positive and negative training sets can vary in size significantly.
A system for building automatic classifiers is integrated into CellVisualizer [2],
our visualization and analysis system. Users label cells via a drag-and-drop interface,
shown in figure 4-3. The user can request more cells with positive or negative labels,
sampled from the full screen or a specific control image (useful for seeding the classifier
with a few known examples). The user can ask for cells near the decision boundary, in
which case several times more cells than they request are randomly sampled, and those
with the least decisive labeling are returned to the user. They can check the classifier's
behavior on a test image, seeing every phenotype-positive cell as defined by the current
classifier, an especially useful operation on images of positive or negative controls. A
training set typically needs to be between 100-1000 cells to train a sufficiently accurate
classifier. The drag-and-drop interface makes this process very fast, on the order of
a hundred cells per hour.
4.3 Summary
We have demonstrated how cells can be labeled according to phenotype, using their
cytological profiles. Some phenotypes are simple, i.e. defined in terms of one or
a few measurements, and rules to label cells based on these measurements can be
crafted manually. In other cases, the phenotype is easily distinguished visually, but
the connection to measurements from image processing is less obvious. In this case,
we rely on human guidance, and use example-based image retrieval [91] to quickly
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build a training set. We can search for multiple phenotypes within a screen, simply
by defining a new classifier or set of rules for phenotype.
In our work, we use GentleBoosting and decision stumps to train the automatic
classifier [33]. Others have used automatic classifiers to label individual cells according
to phenotype. Boland & Murphy use neural networks to classify cells by which
subcellular compartment contains a particular stained protein [13]. Harder et al.
use support vector machines to classify cells according to their phase in the cell cycle,
based on nuclear appearance only [40, 41, 53], as part of the MitoCheck project
[3]. In a drug-based (rather than genetics-based) screen, Looet al. [64] use linear
support vector machines to classify individual cells under treatment with different
drugs and chemical compounds, treating every cell under treatment as having the
same phenotype. However, they then extract the normal to the decision boundary to
use as a signature for each compound, rather than using the classifications directly.
We note that we do not believe that the particular choice of classifier algorithm
and training method is vital to our approach; any reasonable method would work.
GentleBoosting has some traits that make classification of a large number of cells
more tractable, primarily its sparsity and the simplicity (in terms of translation to a
database query) of the resulting classifier.
In the next chapter, we show how we can score genes according to how reduc-
ing their expression affects the number of cells showing a phenotype, and use this
information to predict related genes.
Chapter 5
From Phenotypes to Phenotype
Profiles and Related Genes
Once every cell in a screen has been categorized as having a phenotype or not, we
calculate, for each knockdown, a score corresponding to how much knocking down
that gene enhances or suppresses that phenotype. Those genes whose knockdowns
significantly enhance or suppress the same phenotype are predicted to be related.
To quantify the amount a knockdown enhances or suppresses a phenotype, we
fit a probabilistic model to the screen-wide set of phenotype-positive and phenotype-
negative counts, and score knockdowns according to how they deviate from the model.
Some variability is inherent in large screens, from slight changes in experimental
conditions between knockdowns, and our model takes this into account. We use
methods from Bayesian hypothesis testing, with a scoring function that represents our
belief that a knockdown causes an increase or decrease in the number of phenotype-
positive cells.
We combine the scores from individual knockdowns targeted to the same gene,
giving us a score for each gene probed in the screen. We explicitly adjust for the pos-
sibility of off-target effects when combining scores from knockdowns; the adjustment
in the scoring function has a regularizing effect that keeps us from giving too much
credence to a single knockdown's effect.
The genes that most strongly affect the balance of phenotype-positive and phenotype-
negative cells are predicted to have related function. As discussed in the introduction,
we use similarity of appearance as a proxy for similarity of function. Phenotypes are
our vehicle for quantifying similarity of appearance.
5.1 Scoring Genes
For every gene knockdown, we have two hypotheses. Either the knockdown enhances
the phenotype (He,kd), causing more cells to show that phenotype than expected, or
it suppresses the phenotype (H,,kd), resulting in fewer than expected cells having the
phenotype. For each knockdown, we have two values: the total number of cells found
in the corresponding image (tkd), and the number of cells showing the phenotype for
that knockdown (nkd). For each knockdown, we wish to compare P(He,kdltkd, nkd)
and P(Hs,kdltkd, nkd)
In order to quantitatively evaluate these hypotheses, we must find a model that
fits the data in an meaningful and accurate manner.
If each cell were completely independent from all other cells in the screen, and
if we assumed that for a particular phenotype, the vast majority of genes have no
effect on the the fraction of cells showing the phenotype, then a good model would
be to find the screen-wide fraction p of phenotype-positive cells, and treat each cell's
appearance with regard to the phenotype as an independent draw from a Bernoulli
random distribution with probability of success p. In this case, every knockdown could
be scored according to its deviation from the Binomial distribution with parameters
tkd and p.
However, this simple model does not accurately represent the observed results
from actual screens. In figure 5-1, the fraction of phenotype-positive cells for each
knockdown in a screen are presented as histograms, for two different phenotypes.
Superimposed on the histograms are analytic distributions using the binomial model
above. It is obvious that the binomial model has a much narrower distribution than
the actual values from the screens. Other plausible distributions, such as Poisson, pro-
duce similar results: a narrow peak near the mean with large number of knockdowns
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Figure 5-1: Histograms of phenotype-positive fraction of cells across gene knockdowns
for a screen and a Binomial model fit to the corresponding data. The median fraction
of phenotype-positive cells across knockdowns was used as the probability of success
for the binomial. On the left, the phenotype is cells in G2 phase of the cell-cycle 4-1.
On the right, cells with crescent-shaped nuclei.
deviating significantly above or below the mean.
The simple binomial model above assumes each cell's phenotype is independently
drawn from a single distribution. Given our knowledge of experimental imperfections
such as plate effects, staining variation, and other sources of error, we would expect
that each group of cells in an well has grown under slightly different conditions, even
after taking into account the different gene knockdowns. We believe that screens be-
have in a more hierarchical manner: each well in a plate or spot on a slide has a slightly
different environment, and these environmental differences perturb the balance be-
tween phenotype-positive and -negative cell numbers. The single, shared binomial
model is not flexible enough to encompass the variability between knockdowns.
To incorporate these effects and model the resulting overdispersion, we move to
a slightly more complex model, in which the variability of the probability of a cell
having the phenotype is allowed to change from knockdown to knockdown.
The Beta-Binomial Model
Let us consider multiple knockdowns, each with some number of cells that show a
phenotype according to some unknown distribution. Based on experimental data, we
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Figure 5-2: The Beta-Binomial model for a phenotypic analysis of a screen. a and /
are the shape parameters of the Beta distribution, from which the probability Pkd Of
a cell showing the phenotype is drawn, independently for each gene gi. The tkds are
the total number of cells for each gene, and treated as fixed parameters of the model.
The observations are nkd, the number of cells showing the phenotype for each gene.
We fit a and 3 to the data, with the pkd as hidden variables.
believe that the probability of a cell showing the phenotype varies from knockdown to
knockdown, even for knockdowns having no effect on the phenotype. A natural way
to model that variability is to assume that each cell under a particular knockdown
has an identical probability of showing the phenotype, but that this probability is
drawn independently for each knockdown from some overarching distribution. The
Beta-Binomial is an example of such a model. Under this model, for each knockdown
a probability of success Pkd is drawn independently from a Beta distribution. Every
cell grown in that condition has probability Pkd of showing the phenotype, and the
total number of phenotype positive cells for that knockdown, nkd, is drawn from a
Binomial distribution.
This model, first proposed by Skellam [88], can be written as
PBetaBinomial(nja, 3; t) = Psinomial(nlp; t)PBeta(pc, ,3)dp (5.1)
S(t) B(a +n,3 + t - n) (5.2)
n B(a, /)
where n is the number of successes (phenotype positive cells), t the number of trials
(total number of cells), and B(a, p) is the Beta distribution with shape parameters
a and p. The Beta distribution is flexible enough to exhibit a variety of shapes on
[0, 1]. The full probability for the data from a screen is just the product of equation
5.2 evaluated for each knockdown,
K
P(nlc , ); t) = f PBetaBinomial(nkdIa, 3; tkdi), (5.3)
i=1
where n and t are the full set of phenotype-positive and total cells across the knock-
downs kdl...kdK. Note that we are assuming that there are few outliers, i.e., knock-
downs that significantly affect the relative number of phenotype-positive and -negative
cells, and these outliers do not significantly skew the fit of the model to the data.
Our goal is to find genes that affect the relative number of phenotype-positive
cells, and we are less concerned with overall cell viability. For this reason, we do not
try to model the total number of cells, and treat the tkd as fixed parameters, rather
than random variables. The resulting model is shown in graphical form in figure 5-2.
The integral in equation 5.2 can be computed in closed form, and fitting the model
to data with the maximum likelihood estimate is feasible with standard numerical
techniques. As in Lowe [65], we reparameterize the Beta function's a and 3 with
a 1
a = = 1 (5.4)a+P a+0)
such that y is the expected probability of the phenotype drawn from the Beta distri-
bution, and v is a term corresponding to the "width" of the Beta distribution. We
form estimates /i and V by maximizing the full screen's log-likelihood with standard
numerical optimization. We use the screen-wide fraction of phenotype-positive cells
as the initial guess for p, and a fixed initial guess of 0.5 for v.
In figure 5-3, we show the new model fit to the data previously discussed in figure
5-1. The improvement is clearly apparent.
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Figure 5-3: Histograms of phenotype-positive fraction of cells across gene knockdowns
for a screen and a Beta-Binomial model fit to the corresponding data. On the left, the
phenotype is cells in G2. On the right, cells with crescent-shaped nuclei. Compare to
figure 5-1. Note that although the fit to the distribution on the left is not necessarily
better under any particular measure of goodness-of-fit, it results in far fewer outliers.
Comparing Hypotheses with the Beta-Binomial Model
With the estimates for the parameters of the Beta-Binomial model, we now wish
to compare the two hypotheses, P(He,kdlnkd; i 2, iA , tkd) and P(Hs,kd nkd; Ai, i, tkd) (en-
hancement and suppression, respectively) for each knockdown. We rewrite these
probabilities via Bayes' Rule,
P(He,kdlnkd; A, k, tkd) =
P(Hs,kdlnkd; f^, ^, tkd) =
P(nkd He,kd)P(He,kd)
P(nkd)
P(nkd H PH,kd)P(Hs,kd)
P(nkd)
(temporarily dropping the model parameters for clarity).
For reasons that will be explained in the next chapter, we do more than simply
decide between the two hypotheses He,kd and Hs,kd for each knockdown. Instead, we
calculate the log-likelihood ratio of the hypotheses, and use it as a scoring function
for each knockdown. Thus, for each knockdown we compute
log P(He,kdlnkd) P( l kd He,kd)+ C(Hkdlog = log + CP(nkdH, (5.7)d)
P (H8 ,kd nkd) P(nkdI H,kd)
(5.5)
(5.6)
M06-MdL___ I0.6 08 1.0
where C is a constant offset equal to log P(H , which we will take to be zero (i.e.,
enrichment and suppression are equally likely a priori), for now.
How are we to interpret the conditional probabilities P(nkdlHe,kd) and P(nkdjHs,kd)?
What does it mean for the hypothesis He,kd to be true? We interpret He,kd as an event
that the hidden parameter Pkd, the probability of expressing the phenotype of inter-
est, is from a Beta distribution with larger expected value than A estimated above
(but the same i), and similarly for Hs,kd. Under this interpretation, the conditional
probabilities can be expressed as,
P(nkd He,kd; A, k, tkd) = PBetaBinomial (nkdlm, ; tkd)dm (5.8)
P(nkdlHs,kd; , tkd) = PBetaBinomial(nkdlm, V; tkd)dm, (5.9)
where we have assumed that Vi is unchanged under the enriched and suppressed hy-
potheses, we have placed a uniform (uninformative) prior on values for the expectation
parameter m of the Beta Binomial under each hypothesis, and Ze and Z, are nor-
malizations that constrain P(nkd|He,kd, nkd = ftkd; ... ) = - (i.e., if nkd is its expected
value from the Beta-Binomial model, there is no evidence for or against enhancement
or suppression). We combine these equations with equation 5.7, to obtain
P(He,kdlnkd) l 1 PBetaBinomial (nkdm, 9; tkd)dmlog = log (5.10)
P(Hs,kdlnkd) fl PBetaBinomial (nkd m, i; tkd)dm
Using this model and the equations for evaluating relative enrichment and suppres-
sion, we can score every knockdown in a screen.
5.1.1 Scoring Genes from Gene Knockdowns
As discussed in section 2.1, there are usually 5-10 unique knockdowns (in the form
of short hairpin RNAs) targeted to each gene, across the set of genes screened in our
data. In the ideal case, we could combine the evidence from each knockdown targeted
to a gene as the sum of log-likelihood scores for that gene's knockdowns, as
log PBetainomia1(nkdm, ; tkd)dm (5.11)log ý (5.11)
kdEkds(A) f0l PBetaBinomial (nkdlm, V; tkd)dm
where kds(A) is the set of knockdowns targeted to a particular gene A, and the
individual knockdowns in kds(A) are assumed to be independent, given the targeted
gene. For the data and screen we present here, this is a reasonable assumption, as a
design goal when constructing the shRNAs for this screen was that hairpins targeted
to the same gene should be well-separated from each other along the gene's sequence.
However, equation 5.11 neglects an important consideration in knockdown screens:
the correspondence between knockdowns and genes is not perfect, nor are knockdowns
always effective. In particular, shRNA screens are subject to a large percentage
of knockdowns that fail to reduce the targeted gene's expression level, as well as
mismatches resulting in reducing the expression of some other gene, so-called off-
target effects. In fact, a single hairpin may suppress expression of multiple genes,
each to a different level. In the library of knockdown vectors from which the data
presented here was generated, about 40% of hairpins reduce their intended gene's
expression significantly. Even when knockdown from a "good" hairpin produces a
distinct phenotype, about one tenth of the time that phenotype is due to an off-
target effect, i.e., some other gene's expression being reduced as well [82]. To account
for the possibility of off-target effects, we adjust our scoring function to account for
this disconnect between the individual knockdowns and their targeted genes.
From the information above (40% working rate, 10% repeatability of phenotypes
in working knockdowns), we can estimate the probability that a gene's successful
knockdown (without any off-target effects) produces the same effect on cells as one
of the hairpins targeting it as (.4)(.9) + (.6)(.5) =- 2, where we have assumed that
non-working hairpins enrich or suppress the phenotype of cells randomly and in an
unbiased way. We use this value as we combine posteriors from individual knockdowns
into a score for the gene they target, while taking into account off-target and non-
working hairpins, as
P(He,Alnkd) P(,A ,kd) (He iH P(He,kdlnkd) + P(He,A Hs ,kd)P(Hs,kdlnkd)
P(Hs,Akd kdkd(A) P(Hs,A IH,kd)P(Hs,kdlnkd) + P(Hs,AIHe,kd)P(He,kdlnkd)
(5.12)
where A is some gene, He,A the hypothesis that successfully knocking down just A
enriches the phenotype, kds(A) is the set of knockdowns targeted to A, and we have
P(He,AIHe,kd) = P(He,AIHe,kd, nkd) = 3 and P(He,AIHs,kd) = P(He,AIHs,kd, nkd) = ,
and similar values for P(HS,A ... ).
The additional terms in the numerator and denominator of equation 5.12 act as
a regularizer. For a single knockdown, when P(He,kdlnkd) , 1, the maximum effect
on the targeted gene's score from that knockdown is log P(He,AIHe,kd) Similarly, whenP(H.,A1He,kd)"
P(Hs,kdlnkd) r 1, the effect on the score is bounded below by log P(He,AH,kd) Thus,
the probability of a phenotype presenting due to an off-target effect provides an upper
and lower bound on the evidence from any single knockdown. When P(He,kdlnkd) =
P(Hs,kdlnkd), i.e., there is no real evidence for enhancement versus suppression of the
phenotype, the hairpin's score does not affect the gene's score, as expected.
It remains to estimate C in equation 5.7, which is straightforward using controls,
or from the median score across the knockdowns, under the assumption that most
genes have no effect on a particular phenotype. We leave C = 0 in this work, as it
does not deviate too far from that value in our experiments, regardless of the method
used to calculate it.
5.1.2 Phenotype Profiles and Predicting Related Genes
We refer to the set of genes and their scores from equation 5.12 as a phenotype
profile. For each phenotype we analyze in a screen, there is a corresponding phenotype
profile. The parallel with expression profiles is intentional. In an expression profile,
genes are "scored" based on their relative expression levels between two conditions,
while in phenotype profiles, we score genes based on how changing their expression
levels changes relative number of phenotype positive cells. The connection between
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Figure 5-4: Phenotype profile for 4N phospho-histone H3 negative cells. The genes
are sorted by decreasing score, left-to-right, i.e., genes that enhance the phenotype
are on the left. Marked on the upper view of the profile are genes annotated as being
cell-cycle related [15]. This set is significantly biased to the left, i.e., genes that cause
G2 phase cells (p-value of 0.018 from permutation testing)
expression and phenotype profiles is explored in the next chapter.
We show an example of a phenotype profile in figure 5-4 for the phenotype of 4N
phospho-histone H3-negative (G2 phase) cells, as defined by gating the lower-right
subpopulation in figure 4-2. Genes annotated as being involved in the cell cycle are
marked in the (sorted) phenotype profile, and these genes are significantly biased
towards larger positive scores (p-value of 0.018, as calculated by methods discussed
in the next chapter), indicating that such genes cause an increase in cells in the G2
phase, validating the phenotype as cell-cycle related. In the screen, knockdowns for
847 genes pass quality control (e.g., filters for successful infection, cf. chapter 2).
The genes that score most strongly for a particular phenotype are those that we
predict to be related though some common biological mechanism or function. Our
work does not allow direct predictions of which genes might interact directly due
to the gulf between cellular phenotypes and genetic networks. Rather, our methods
should be viewed as an attention focusing device and generator of hypotheses for
more direct investigation in the laboratory.
~~~"~
5.2 Summary
In this chapter, we have introduced methods for scoring individual knockdowns via
a screen-wide probabilistic model of the distribution of phenotype-positive and -
negative cells. We choose a Beta-Binomial model, as it allows us to account for
the natural variation in the fraction of cells showing a phenotype, separate from the
effects of the actual gene knockdowns.
Our scores are represented as the log likelihood ratio of two hypotheses, that
a knockdown enriches the phenotype or that it suppresses it. We do not use the
scores to choose a particular hypotheses, but rather maintain them as indicators of
belief. This allows us to combine scores from knockdowns into scores for genes in
a straightforward manner. Our method for combining knockdown scores explicitly
includes the possibility of off-target effects. Modeling off-target effects can be seen as
acting as a regularizer on knockdown scores as they are combined into gene scores,
preventing any single knockdown from unduly affecting its targeted gene's score.
We refer to the set of genes and their scores from a single phenotype as a phenotype
profile. This representation is similar to that proposed by Friedman and Perrimon
[32]. The intention, there and here, is to represent continuous information about
screening data, whether motivated by a view of genetic interaction networks as more
graded than simple on/off interactions, or, in our case, by the noisy readouts of the
effects of genes as modulated through a particular phenotype.
Our model for scoring allows only two possibilities for each knockdown: enrich-
ment or suppression of the phenotype. We assume that most knockdowns do not
actually affect the balance of phenotypes, implying that most log-likelihood ratios
will be be near zero. This is the case, but exploring a model with an additional null-
effect class would be valuable. We also adjust the priors of the two hypotheses such
that knockdowns with the expected number of phenotype-positive cells have a zero
log-likelihood ratio. Alternatively, these priors and other model parameters could be
estimated directly from the data via a mixture model. This would likely be effective
for a model that included a null-effect component, as well.
In the next chapter, we use phenotype profiles to make predictions about the
biological mechanisms of that phenotype, and by extension, the genes that most
strongly affect it.
Chapter 6
From Phenotype Profiles to
Biological Function
We have shown how to score genes according to their effect on a phenotype, to form
a phenotype profile of the genes. We predict that the highest scoring genes are more
likely to be related, in terms of gene function. If the phenotype being scored is
biologically interpretable, the set of high-scoring genes may be sufficient to suggest
biological experiments to validate the prediction that they are related. However,
there are cases when knowledge of the phenotype is quite limited. It may have been
encountered during a screen, and while easily identified, nothing more may be known
about the phenotype. Alternatively, some of the biological basis of the phenotype
might have been established, but further insight is desired.
In this chapter, we show how we can establish connections between phenotype
profiles and existing biological data to predict the biological basis of a phenotype,
and by association, the biological function of the genes that affect that phenotype.
6.1 Methods for Connecting to Existing Biological
Knowledge
Recall from the previous chapter that a phenotype profile is the set of scores,
P(gene enhances phenotype)
P(gene suppresses phenotype)'
estimated for each gene in the screen, and computed in terms of models for the
distribution of phenotype-positive cells, and the connection between knockdowns'
and their targeted genes' effects on the phenotype of interest.
We will treat these scores similarly to expression profiles, which represent relative
levels of genes or gene products in cells (e.g., DNA, mRNA, proteins, see chapter 2),
comparing two different conditions, often control and perturbed (such as by a drug)
states. In our case, we have measured the change in cells due to a change in a gene's
expression, rather than the change in a gene's expression due to a change in cells. The
interpretation of the scores is the same, however: a large score for a gene indicates a
probable connection between the gene and the cellular change.
To biologically interpret phenotype profiles, we will use existing tools for corre-
lating gene scores and existing datasets. We will explore two tools, here, Gene Set
Enrichment Analysis [89] and the Connectivity Map [55]. There are several other
tools available that could be applied, as well, most geared toward helping to interpret
or make predictions from expression profiles.
Gene Set Enrichment Analysis, or GSEA, is based around a large collection of
gene sets. Each gene in a set shares a common trait with other genes in that set,
such as common biological function, proximity on a chromosome, common regulatory
motif, shared membership in a particular genetic pathway, and so on. These sets have
been gathered from a variety of sources, including computational analysis of genome
and expression data, as well as curation from published papers. At the current time,
GSEA includes a few thousand gene sets, with more added regularly.
GSEA's input is an expression profile. For each set S in its database, GSEA
computes an enrichments score (ES(S)) relative to that profile, based on a weighted
form of the Kolmogorov-Smirnov statistic,
PhIrt(Si)= j where Nr = 7 Irjl (6.2)
9jES giES
j<i
Pmiss(S, i)= N-Ns (6.3)
gj~sj<i
D(S, i) = Phit(S, i) - Pmiss(S, i) (6.4)
ES(S) = argmax ID(S, i), (6.5)
D(S,i)
where gj and rj are the jth gene and its score in the profile, respectively, S the
gene set being scored in GSEA, Ns the number of genes in the profile that are also
in S (note that expression and phenotype profiles are not always over the same set
of genes). When p = 0, the enrichment score is the standard Kolmogorov-Smirnov
statistic. When p = 1, the enrichment score weights the genes in S by their score in
the profile, normalized by the sum of correlations over all the genes in S, essentially a
weighted correlation. As suggested in the original work on GSEA [89], we use p = 1.
To assess significance, GSEA permutes the gene labels gj relative to the scores rj
many times, and recomputes ES(S) to estimate the null distribution.
Returning to the 4N phospho-histone H3-negative (G2 phase) phenotype from the
previous chapters, we show the GSEA result for a set of genes annotated as cell-cycle
related by Brentani et al. [15] in figure 6-1 (an expanded form of figure 5-4. The
elements of S that are also in the phenotype profile are marked by the vertical black
bars overlaid on the color-coded phenotype profile. The enrichment score ES(S) (the
maximum deviation of the running enrichment score D(S)) is about 0.43, which has
a p-value of 0.018 from permutation testing with 10,000 permutations. This gene set
is significantly biased towards genes that cause an increase in G2 phase cells.
The Connectivity Map [55] takes an obverse approach to GSEA: it relies on a large
collection of expression profiles. Each expression profile compares gene expression
levels in cells under control conditions to expression levels when the cells are treated
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Figure 6-1: GSEA scoring cell-cycle genes against phenotype profile for 4N phospho-
histone H3 negative (G2 phase) cells. The upper graph shows the running score
D(S), with the enrichment score ES(S) equal to D(S)'s maximum deviation from
zero. Steps up in D(S) occur when genes in the profile are also in S, also shown as
black lines in the lower plot. This set is significantly biased to the left (p-value of
0.018 from permutation testing)
with a drug or chemical. At the time of writing, the Connectivity Map contains 453
mRNA expression profiles for 164 different combinations of compounds and cell lines.
The Connectivity Map's input is two sets of genes taken from experiment: upreg-
ulated and downregulated, relative to controls or comparing two tissue types (e.g.,
cancerous and benign tumors). For each differential expression profile in its database,
it computes a similar score to that of GSEA for the up- and down-regulated input
sets. For sets S,, and Sdn and a profile R, the Connectivity Map score is computed
t4
o
ae
Phit(RSi) = 1 (6.6)
gjESS
j<i
Pmiss(RS, i) = N Ns (6.7)
g3Osji
D(R, S, i) = Phit(R, S, i) - Pmiss(R, S, i) (6.8)
CS(R) = argmax D(R, S.,, i) - argmax ID(R, Sdown, i)1, (6.9)
D(R,S>,,i) D(R,Sdown,i)
which is essentially the difference of the ES(SUp) and ES(Sdown) scores from GSEA,
with p = 0, which is also the difference in the Kolmogorov-Smirnov statistics of
SUP and Sdon relative to R. The score CS(R) is computed for every profile in the
Connectivity Map database. Many of the chemicals and drugs in the the database
are represented multiple times, often with varying concentrations. This allows some
evaluation of significance from permutation testing, by comparing the average CS(R)
for the multiple profiles of one chemical to the distribution of the average score of
randomly selected set of the same size.
We apply these tools directly to phenotype profiles, exactly as we would if they
were expression profiles. Doing so with GSEA is trivial. To apply the Connectiv-
ity Map, it is necessary to choose score thresholds to generate the upregulated and
downregulated sets, which in our case are genes that enhance and suppress the phe-
notype, respectively. In general, we choose a positive and negative threshold at the
same absolute log-likelihood score, near the knee in the curve of the phenotype pro-
file scores (see figure 6-1), usually resulting in around fifty genes in each set. We
have not investigated a more principled approach to choosing these thresholds. As
part of the validation of our methods, we analyzed the G2-phase phenotype with the
Connectivity Map. The results of this analysis are presented in the next chapter.
The correlations found by these tools allow us to form predictions of the biological
significance of the phenotype of interest. Just as when these tools are used on ex-
pression data, they are intended as hypotheses to steer scientists' attention, suggest
Figure 6-2: An example gene network regulating a phenotype.
Expression of gene A positively regulates gene B. Increased
A-- B- C expression of B suppresses the phenotype, while increasing ex-pression of C. Knockdown of A or B enhances the phenotype.I From the true network, we would expect gene C's expression
phenotype to be low in cells showing the phenotype. However, actual
knockdown of C would not affect the phenotype, preventing
us from correctly estimating its expression in this phenotype's
profile.
new avenues of exploration, and help validate prior results.
6.2 An Interpretation of Phenotype Profiles
Phenotype profiles are estimations of whether a particular gene's knockdown causes
more or fewer cells to take on some phenotype. We treat them analogously to expres-
sion profiles, in order to find correlations between genes that cause the phenotype
and possible explanations for how they do so. We interpret strong correlations as
evidence that some genetic pathway, biological system, or drug's method of action is
related to the phenotype, via a sort of "guilt by association."
A gene's score in a phenotype profile is a quantification of the evidence about the
effect of reducing that gene's expression. However, we can interpret phenotype profiles
in another way, as noisy estimations of gene expression in cells showing a particular
phenotype. This interpretation can be seen as a (loose) application of Bayes's law:
P(phenotype present I gene expression reduced) oc
P(gene expression reduced I phenotype present)
This estimation is noisy, of course, and dramatically simplified from the realities
of genetic regulation. Even without considering noise, there is no concept of causality
or parallel effects present in this model. As an example, consider the network in
figure 6-2. Gene A positive regulates gene B, while B negatively regulates some
phenotype and positively regulating gene C. Knocking down the expression of gene
A or B results in an increase in the phenotype, while knocking down C does not
significantly affect the phenotype. By our methods, we would estimate that A and B
are underexpressed in cells showing the phenotype, but that C's level is unchanged in
them. Yet, depending on how tightly coupled gene B's expression and the phenotype
are, C would be underexpressed in these cells. It is fairly easy to construct other
counterexamples. In general, we can only claim to have estimated the expression
levels of genes "upstream" of a phenotype. Our hope is that the knockdowns of
unrelated and "downstream" genes do not affect the phenotype too much.
Phenotype profiles should not be taken as true expression profiles, by any means,
but this approach does provide us with some intuition for interpreting them and
the results from tools such as GSEA and the Connectivity Map. Our use of large
ensembles of scores when interpreting phenotypes, the full profile in the case of GSEA
and sets of high- and low-scoring genes for the Connectivity Map, is in part motivated
by the need to incorporate a large amount of data to overcome the noise and failures
of estimation above.
6.3 Summary
This chapter introduces methods for connecting phenotype profiles to biological data.
We use existing tools which seek correlations between sets of genes and expression
profiles, or in our case, phenotype profiles.
A strong correlation between a phenotype profile and some aspect of known biol-
ogy leads us to predict a relationship between the phenotype generating the phenotype
profile and that biological aspect, and by association, to predict a relation between
that known biology and the genes that score most strongly in relation to the phe-
notype. The existing data might be known genetic pathway, a set of genes with a
common annotation, genes differentially expressed in one tissue type compared to
some other, a drug or chemical's effect on gene expression, or from a number of other
sources. We have validated these approaches on a cell-cycle related test case, which
we explore further in the next chapter.
We have also explored an interpretation of phenotype profiles as estimates of
expression profiles from phenotype information. This interpretation provides us with
intuition as to why we expect expression analysis tools to be effective when applied
to phenotype profiles, and what the correlations they might find indicate about the
phenotypes we apply them to.
In the next and final chapter, we present results from and further validation of
the methods and techniques we have introduced in this and prior chapters, applied
to predicting related genes and their underlying biological functions.
Chapter 7
Results
We present validation of and novel results from our methods in this chapter. For
validation purposes, we look at two cases, cells in the G2 phase of the cell cycle, and
cells undergoing cytokinesis.
We present results for several phenotypes that have not been previously studied.
For those phenotypes, we present predictions for the biological mechanisms of the
phenotype, where possible.
Our image processing and cell measurement methods have been validated sepa-
rately, as discussed in previous chapters, but also through their application to a variety
of screens and other quantitative imaging problems [8, 9, 17, 22, 42, 56, 71, 99].
7.1 Cell Cycle Control Genes
We return to the 4N phospho-histone H3-negative (G2-phase) phenotype, as a positive
control for the methods introduced in this dissertation. We generated a phenotype
profile from the scores for each gene, and processed it with Gene Set Enrichment
Analysis to find which gene sets show a significant correlation with the profile. The
highest scoring gene sets are listed in table 7.1, as ordered by p-value from GSEA's
permutation testing.
Of those gene sets scoring with a positive enrichment score (i.e., with gene sets
more likely to cause the G2 phenotype when knocked down), seven of ten are cell cycle
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related. We have listed gene sets that negatively correlate with genes that cause the
phenotype, though these are not as directly interpretable as cell-cycle related. We
have noticed this to commonly be the case, possible reasons for which we discuss
below.
We generated an anaphase vs. metaphase phenotype profile, in which we consid-
ered anaphase cells as phenotype-positive and metaphase as negative, but ignored all
other cells. This is a useful technique for evaluating putatively related phenotypes
where cells not in either phenotype might dominate the computation. In this case,
most other cells are in some other phase of the cell cycle, such as G1 or G2.
In this case, because of the lower number of cells showing either phenotype (around
3% of all cells), we expect lower accuracy from any predicted gene function. The re-
sults from GSEA are shown in table 7.2. Again, several cell-cycle related sets appear,
including one with known specific function in the metaphase/anaphase transition (loss
of the gene Apc [38, 50]). Note that several related gene sets appear multiple times,
including three related to mouse hematopoietic stem cells from three slightly different
characterizations of these genes, two related to granulosa cells, and up- and downregu-
lated genes in Wilms' tumor. These repeats are an artifact of their overrepresentation
in GSEA's database of gene sets.
We analyzed the G2 phenotype with the Connectivity Map. The top five most
significant results for this phenotype are shown in table 7.3. Many drugs affect the
cell cycle (particularly those used in the treatment of cancer, many of which are
present in the Connectivity Map's database), so it is unsurprising that a link between
the drugs listed in table 7.3 and the cell cycle can be established. The table lists a
citation deemed most plausible for the screened cell line (HT29) and this phenotype
(G2), from the large number available for each compound tying it to the cell cycle.
We analyzed the anaphase vs. metaphase phenotype via the Connectivity Map,
with similar results. The two most strongly scoring compounds for this phenotype
were LY-294002 (also scoring in the G2 phenotype), which is known to affect the
anaphase-metaphase transition [43, 75], and all-trans retinoic acid, known to affect
proliferation in the HT29 cell line (the line used in this screen) [73]. We should note
Count Mean score
LY-294002
Valproic acid
Rosiglitazone
Nu-1025
Prochlorperazine
PI3K inhibitor
HDAC1 inhibitor
Ppary activator
PARP inhibitor
Calmodulin inhibitor
Table 7.3: Compounds that correlate with the G2/4N phenotype profile in the Con-
nectivity Map. Positive scores indicate positive correlation between the up- and
downregulated sets of genes. Note that knockdown experiments reduce gene expres-
sion, so we expect negative scores to positive correlate with the phenotype-positive
cells. Count is the number of times the compound appears in the connectivity map
database (as a replicate or under a different concentration), across which we calculate
a mean score. P-values are determined by permutation of expression profiles (not of
genes in the up- and downregulated sets). Citations listed were selected based on
plausibility of explanation for the connection to the cell-cycle.
that the Connectivity Map was generated by profiling expression in several different
cell lines, but primarily in MCF7 cells (a breast cancer line). Neither the HT29 cell
line, nor any other colon cancer cell lines, were used to create the profiles. As many
drugs affect cells in a very tissue-specific manner, the hypotheses generated from
the Connectivity Map should be balanced by the similarities in drug-response from
cell-line to cell-line.
7.2 Novel Phenotypes
We now consider some of the complex visual phenotypes from figure 1-2, and their
possible interpretations from phenotype-profile analysis. Some of these phenotypes
were discovered in the initial screen [71], others when following up earlier phenotypes
or during analysis of a priori interesting cytological measurements, such as cell size
or eccentricity.
-0.515
0.101
-0.224
-0.644
-0.385
0.0001
0.0145
0.0208
0.0233
0.0457
[87]
[86]
[44]
[69]
[47]
p-value CitationName Type
Actin Dots
This phenotype, with dots of actin at cell junctions, appears to be related to cell
adhesion, based on the most strongly scoring genes and the results from GSEA. The
most strongly scoring genes are listed in table 7.4, along with possible links to cellular
focal adhesions, the cytoskeletal links from a cell its exterior. The results from GSEA
analysis are shown in table 7.5. We discuss this phenotype in conjunction with the
Actin Ring phenotype, below, for reasons that will become clear.
Gene Score Connection to focal adhesion?
SFRS2 2.25 none known
PKIA 1.28 none known
PTPRC 1.10 focal adhesion GO term [6] from sequence similarity
PTPRB 1.10 yes [5]
TRPM6 1.09 possibly, via association with TRPM7 [21]
TEC -1.36 none known, (same family as TXK)
STK17A -1.37 none known
PPP1R12A -1.40 yes, in focal adhesion pathway (Kegg [49])
LCK -1.54 yes, [37]
TXK -1.64 none known, (same family as TEC)
PRKCZ -2.06 maybe, involved in cell-cell (tight) junctions (Kegg [49])
DAPK3 -2.10 maybe, (interacts with PRKCZ in vitro [16])
Table 7.4: Top scoring genes for the Actin Dots phenotype. Several genes are directly
or closely related to focal adhesions in cells.
Actin Ring
The Actin Ring phenotype shows an increased concentration of cytoskeletal mate-
rial and a smooth cell border. The appearance of the cells indicates a reorganization
of the cytoskeleton, similar to that caused by toxins released by some bacteria, espe-
cially Bacteroides fragilis [84]. The GSEA analysis of this phenotype, listed in table
7.6, indicate two interesting results. First, this phenotype is anticorrelated with the
Actin Dots phenotype, indicating similar underlying mechanisms, operating in an
opposite fashion. Second, the connection to human cytomegalovirus (HCMV, mem-
ber of the herpesvirus family), which is known to cause reorganization of the actin
cytoskeleton, and causes a similar phenotype in HT29 cells (cf. figure 9 of [10]). The
reorganization of the cytoskeleton may help spread the virus between cells [66]. It
is known that HCMV upregulates 31-integrin receptors in PC3 cells [12], possibly
affecting cell adhesion and cytoskeletal organization, via the integrin-signalling path-
way, and also upregulates the PI3K pathway [45]. Both of these pathways appear in
the GSEA results for this phenotype.
The opposition of the underlying mechanisms for the Actin Ring and Actin Dots
phenotypes opens up the possibility of epistasis studies to determine which genes
(of those scoring highly for either phenotype) are up- or downstream relative to the
phenotype. Such studies are possible with any two phenotypes which are mutually
exclusive, such as 2N versus 4N DNA content or large versus small cells, but more
useful when exploring a more limited portion of the genetic regulatory network.
Crescent Nuclei
One of the most interesting phenotypes we have encountered is one in which the
nuclei are crescent shaped and pressed against the cell membrane, usually by what
appears to be a vacuole (i.e., a membrane-bound compartment interior to the cell).
Often, the cell body appears inflated as well.
One theory being investigated in ongoing experiments is that this phenotype is
due to breakdown of ion balance in the cell, in particular, disregulation of sodium
ion channels. This is based on the large structure in each cell that appears to be a
vacuole, the lack of staining in the vacuole even with a variety of broadly targeted
stains, and a few key genes' knockdowns giving strong phenotypes. In particular, one
of the two hairpins against NEDD4L that pass quality control for infection efficiency
gives a very strong, positive phenotype. NEDD4L is a known inhibitor of ENaC,
a sodium channel protein complex in the cell [48]. Since only two knockdowns of
NEDD4L pass quality control, the gene itself does not score strongly.
Another possibility, from examination of the literature (guided by the GSEA re-
sults discussed below), is that the vacuole is filled with mucin or another substance.
This is based on the phenotype which is very similar to "signet ring cells" [54]. Can-
cers showing this morphology arise in several different organs [72], and patients with
signet ring cell carcinoma (SRCC, defined as more than 50% of tumorous cells show-
ing this phenotype) have a poorer prognosis than non-SRCC carcinoma [74]. The
genes that lead to this phenotype are therefore of interest to understand why SRCC
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responds more poorly to treatment, as well as for possible drug targets. Signet ring
cells are similar in appearance to "goblet cells" [25], which are responsible for mucus
secretion in the intestinal and respiratory tracts. The cell line used in this screen
can be induced to form a mucin-secreting, goblet-cell enriched line by selection under
methotrexate [59] or sodium butyrate [7].
The GSEA results for this phenotype, shown in table 7.7, show evidence in favor
of both of the explanations above, though possibly more strongly the second. Two
of the top hits are sets of genes downregulated by butyrate in a colon-cancer cell line
(SW620) at different time points. Butyrate increases expression of the components
of the ENaC complex [100]. However, butyrate also regulates mucin genes [36] in
HT29 cells, and as mentioned above, selection under butyrate causes enrichment in
cells with this morphology [7]. This phenotype is also seen in pituitary cells when
stimulated with luteinizing hormone releasing hormone (which causes release of both
luteinizing hormone and follicle stimulating hormone) [97], though the presence of
this result in the GSEA list is not necessarily meaningful, given that it also appears
for other phenotypes, such as Actin Rings (cf. table 7.6).
The multitude of possibilities, all linked to phenotypes similar in appearance but
with quite different underlying biology, leads to another explanation: it is possible
that we have detected more than one of the actual mechanisms due to an inability
to distinguish their slight differences in the screen at hand. This is a concern in any
screen, particularly given the technical limitations in staining protocols and imag-
ing. This situation could be improved by screening replicates with different staining
protocols.
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Peas-in-a-pod
The final phenotype we examine in isolation is the "Peas-in-a-pod" phenotype, in
which individual cells clump together in short strings, with limited cytoskeletal bound-
aries between adjacent cells. This phenotype is quite rare, with only a few knockdowns
causing it across the entire screen. The results from GSEA analysis of this phenotype
are shown in table 7.8.
The relative sparseness of this phenotype within the screen limits our confidence in
the hypotheses generated by GSEA. However, the strongest hit, genes downregulated
by tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) in HL-60 cells, a
human leukemia cell line, led us to seek examples of this chemical's effect on HT29
cells (the line from this screen). Although there have been no morphology-oriented
studies of this cell line under TPA treatment, studies of TPA-induced cell scattering
seem to show a similar phenotype in at least three cases: Choi et al. [20, figure 2],
Martin et al. [68, figure 1A(c)], and Rochet-Egly et al. [80, figure 2(b,e,h)]. Although
not conclusive, these examples strongly hint at a connection to scattering and the
underlying biological processes, such as cell-cell contact and extracellular adhesion
[68].
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7.3 Interactions Between Phenotypes
As some of the results above show, many phenotypes interact with one another.
This is especially true of the cell-cycle, which in many ways dominates most other
phenotypes, as any phenotype that does not allow the cell cycle to progress can be
considered an instance of a cell-cycle arrest phenotype.
We visualize interactions between phenotypes by plotting pairwise gene scores for
several of the phenotypes we have explored in figure 7-1. As can be seen, many of the
phenotypes have a cell-cycle dependency (based on the correlation of scores with the
G2 phenotype). The anticorrelation between actin dots and actin rings was explored
above. As would be expected, some phenotypes affect cell-cycle distribution, as shown
in figure 7-2 for the Crescent Nuclei and Fingers phenotypes.
It would be useful to be able to explore the cell-cycle and morphological effects
of these phenotypes separately, but how to do so is an open problem. A simple (but
unsuccessful) approach is to only count cells in a particular phase (such as G2) in
the phenotype-positive and -negative classes for each knockdown. However, as can be
seen in figure 7-3, though this may decrease the dependence between the phenotypes,
the effect is slight, and not generally effective.
One case where it does appear to attenuate the (slight) cell-cycle dependency
is in the Crescent Nuclei phenotype. We reanalyzed this phenotype limited to 4N
cells, with results shown in table 7.9. These results are more difficult to interpret, in
relation to the phenotype, and appear more noisy (note, for example, the presence of
sets upregulated and downregulated in XPC-defective fibroblasts).
Methods
To analyze phenotype profiles with GSEA, we use version 2.0.1 of the source code and
version 2 of the MSigDB (the database of gene sets), limit analysis to gene sets that
overlap with at least 15 and no more than 500 genes in the screen, use the weighted
statistic described in the previous chapter, and use 20,000 permutations to compute
p-values.
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Figure 7-1: Many phenotypes interact with one another. Each small scatterplot shows
the paired per-gene scores from the phenotype profile for that column (horizontal axis)
and row (vertical axis). Many phenotypes have a cell-cycle interaction or effect, as
can be seen in the bottom row of plots. The negative correlation between the Actin
Dot and Actin Ring phenotypes is also apparent.
For the Connectivity Map, for uniformity of analysis, we take the top 100 genes
by magnitude of their log-likelihood score, and break them into upregulated and
downregulated sets by the sign of their score. The Connectivity Map requires input
in the form of probe identifiers on a particular expression array (Affymetrix GeneChip
Human Genome U133A Array,part number 510681). We translate phenotype profiles
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Figure 7-2: Some phenotypes perturb the cell-cycle distribution. From left-to-right,
DNA histograms are shown for control cells, cells with the Crescent Nuclei phenotype,
and cells with the Fingers phenotype. The latter causes a strong bias toward G2/M
(4N) cells.
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Figure 7-3: Limiting phenotypes to a single phase in the cell cycle does not always
remove their dependence. Shown are correlations in scores between three phenotypes
and the G2/4N phenotype. Attempting to control for cell-cycle dependence by limit-
ing phenotype-positive and -negative cell populations to 4N cells does not make the
scores independent in most cases. An exception is the Crescent Nuclei phenotype,
whose slight dependence is further reduced.
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(which are listed by gene) to probes via GSEA's Chip2Chip function. There are often
multiple probes per gene; we include all probes of each of the 100 genes selected by
score, above.
7.4 Summary
In this chapter we have validated our approach to predicting related genes and their
function on two cell-cycle related phenotypes, G2-phase cells and cells undergoing
cytokinesis. We have also presented results on phenotypes not previously studied,
including predictions of genes related to those phenotypes and possible biological
meaning of the phenotypes.
Our results for the several of the phenotypes are quite plausible. The Actin Dots
and Actin Ring phenotypes, which visually seem to involve cell adhesion and spread-
ing, are correlated with gene sets for cellular adhesion, chemotaxis, and cytoskeletal
reorganization by viral infection. Several of the gene sets correlating with the Cres-
cent Nuclei phenotype are known to cause similar phenotypes in the screened cell
line, as well as others.
101
102
Chapter 8
Discussion
In this work, we have demonstrated that is is possible to extract useful information
from images of cells in large gene knockdown screens, and to make meaningful pre-
dictions from this information. In our approach, we first correct systematic biases
in the images, then identify and measure every cell in each image. The collection of
measurements for each cell forms its cytological profile. From the measurements of
the cells, we identify which cells show a particular phenotype of interest. This pheno-
type may be defined by particular measurements on the cells, such as DNA content,
or may be visually apparent. In the latter case, we use human guidance to train a
automatic classifier to identify the cells with the phenotype. We then label every cell
in the screen according to whether it shows the phenotype or not, and compute for
each knockdown the number of phenotype-positive and phenotype-negative cells. We
fit a probabilistic model to these counts, and use that model to score each knockdown
according to our belief that it causes or suppresses the phenotype of interest. We
combine scores from knockdowns into scores for genes, taking into account possible
off-target effects, to form a phenotype profile for the screen and that phenotype. We
use these scores for our prediction of which genes relate to each other, through the
phenotype. To predict the biological meaning of a phenotype, we use existing tools
for expression profile analysis to find correlations between phenotype profiles and
previously known biological information.
We have validated our methods on several phenotypes, some well understood,
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and others not studied previously. For the known phenotypes, we find expected
predictions, while for the new phenotypes, we find predictions that are plausible. In
both cases, we generate hypotheses that merit further exploration in the laboratory
and in future screens.
Our work is one of the first to analyze large screens by measuring and modeling
individual cells, and to the best of our knowledge, the first to use screen-wide scores to
make predictions about the biological meaning of a phenotype. Our image analysis
methods are applicable to a wide variety of cell types and screening and imaging
protocols, and our cell-centric, phenotype-based approach to analysing screen data
enables a much wider variety of biological questions to be answered via large screens.
8.1 Future Directions
There are several areas for future exploration suggested by our work.
A promising avenue would be the unification of image-based chemical biology and
gene knockdown screens. Drug discovery is often a problem of connecting chemicals
to the biological processes they affect, the genes they target, or both. Image-based
screens of known and potential drug compounds have demonstrated the feasibility of
clustering drugs by their effect on cellular phenotypes to predict similarities in biolog-
ical mechanisms [64]. A screen combining gene knockdowns and chemical treatments
would allow several useful biological questions to be answered. For instance, for a
given drug, which gene knockdowns cause similar phenotype changes? This can be
answered by defining a phenotype from the drug's effect on cells, and applying it to
gene-knockdown data. Drug-defined phenotypes would also allow us to predict which
biological process is targeted by the drug, via its phenotype profile. Similarly, finding
drugs that cause a phenotype similar to a that of a particular gene's knockdown would
allow immediate discovery of drugs predicted to act on processes related to that gene.
Our generation and analysis of.phenotype profiles have concentrated, for the most
part, on single phenotypes in isolation. This does not fully model the case where a
gene or genes can affect multiple phenotypes, called pleiotropy. We also do not take
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into account cases where the presence of one phenotype prevents cells from taking on
some other phenotype, similar to the concept of epistasis in genetic networks. A more
nuanced model of the interaction between phenotypes would improve our predictive
ability, by removing confounding factors in the analysis of single phenotypes, and also
open up the possibility of characterizing the hierarchical nature of biological processes
by examining how they exist in epistatic or pleiotropic relationships as revealed by
their effect on phenotypes.
As the number and size of image-based screens grow, data-driven modeling of
phenotypes and their variation becomes feasible. There are many opportunities for
advanced techniques from machine learning to be applied to such data sets, par-
ticularly for automatic phenotype identification. More unsupervised approaches to
feature extraction and measurement of cells is an interesting area of future research.
There are also many opportunities for more direct integration with other sources of
biological knowledge, such as genomic, proteomic, and expression data. A more accu-
rate picture of the relationship between knockdown target sequence and which genes'
expression levels are actually reduced, and by how much, would significantly improve
the generation of phenotype profiles from knockdown scores. Integrating expression
and protein-protein interaction data would allow us to pick out more complex rela-
tionships and strengthen our predictive power. Our methods have been purposefully
constructed in a model-based manner, to allow easy integration of multiple types of
data and sources of evidence.
To conclude, we have demonstrated that meaningful biological predictions can be
made from images of cells, through analysis of the effects of gene knockdowns on
cellular phenotypes. We have introduced methods for measuring individual cells in
images, for using these measurements to classify cells by phenotype, and for modeling
the effects on phenotype for the full set of gene knockdowns in a screen. We use these
methods to predict genes related to one another through a number of phenotypes,
as well as to connect phenotypes with existing biological knowledge to predict gene
function.
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